1.Kraemer, K, Semba, RD, Eggersdorfer, M, et al. (2012) Introduction: the diverse and essential biological functions of vitamins. Ann Nutr Metab 61, 185–191.
2.Semba, RD (2012) The discovery of the vitamins. Int J Vitam Nutr Res 82, 310–315.
3.Paul, BD & Snyder, SH (2010) The unusual amino acid l-ergothioneine is a physiologic cytoprotectant. Cell Death Differ 17, 1134–1140.
4.Cheah, IK & Halliwell, B (2012) Ergothioneine; antioxidant potential, physiological function and role in disease. Biochim Biophys Acta 1822, 784–793.
5.Halliwell, B, Cheah, IK & Drum, CL (2016) Ergothioneine, an adaptive antioxidant for the protection of injured tissues? A hypothesis. Biochem Biophys Res Commun 470, 245–250.
6.Halliwell, B, Cheah, IK & Tang, RMY (2018) Ergothioneine – a diet-derived antioxidant with therapeutic potential. FEBS Lett 592, 3357–3366.
7.Ames, BN (2018) Prolonging healthy aging: longevity vitamins and proteins. Proc Natl Acad Sci U S A 115, 10836–10844.
8.Kerley, RN, McCarthy, C, Kell, DB, et al. (2018) The potential therapeutic effects of ergothioneine in pre-eclampsia. Free Radic Biol Med 117, 145–157.
10.Beelman, RB, Kalaras, MD, John, P, et al. (2019) Micronutrients and bioactive compounds in mushrooms: a recipe for healthy aging? Nutr Today 54, 16–22.
11.Cencic, A & Chingwaru, W (2010) The role of functional foods, nutraceuticals, and food supplements in intestinal health. Nutrients 2, 611–625.
12.Bahadoran, Z, Mirmiran, P & Azizi, F (2013) Dietary polyphenols as potential nutraceuticals in management of diabetes: a review. J Diabetes Metab Disord 12, 43.
13.Ogle, WO, Speisman, RB & Ormerod, BK (2013) Potential of treating age-related depression and cognitive decline with nutraceutical approaches: a mini-review. Gerontology 59, 23–31.
14.Ragle, RL & Sawitzke, AD (2012) Nutraceuticals in the management of osteoarthritis: a critical review. Drugs Aging 29, 717–731.
15.Chauhan, B, Kumar, G, Kalam, N, et al. (2013) Current concepts and prospects of herbal nutraceutical: A review. J Adv Pharm Technol Res 4, 4–8.
16.Borghi, C & Cicero, AF (2017) Nutraceuticals with a clinically detectable blood pressure-lowering effect: a review of available randomized clinical trials and their meta-analyses. Br J Clin Pharmacol 83, 163–171.
17.Aruoma, OI, Coles, LS, Landes, B, et al. (2012) Functional benefits of ergothioneine and fruit- and vegetable-derived nutraceuticals: overview of the supplemental issue contents. Prev Med 54, Suppl., S4–S8.
18.Rathore, H, Prasad, S & Sharma, S (2017) Mushroom nutraceuticals for improved nutrition and better human health: a review. PharmaNutrition 5, 35–46.
19.Espín, JC, García-Conesa, MT & Tomás-Barberán, FA (2007) Nutraceuticals: facts and fiction. Phytochemistry 68, 2986–3008.
20.Sharif, MK & Khalid, R (2018) Nutraceuticals: myths versus realities. In Therapeutic Foods, vol. 8, pp. 3–21 [Holban, AM and Grumezescu, AM, editors]. Cambridge, MA: Academy Press.
21.Singh, S, Razak, MA, Sangam, SR, et al. (2018) The impact of functional food and nutraceuticals in health. In Therapeutic Foods, vol. 8, pp. 23–47 [Holban, AM and Grumezescu, AM, editors]. Cambridge, MA: Academy Press.
22.Spindler, SR, Mote, PL & Flegal, JM (2014) Lifespan effects of simple and complex nutraceutical combinations fed isocalorically to mice. Age (Dordr) 36, 705–718.
23.Poddar, K, Kolge, S, Bezman, L, et al. (2011) Nutraceutical supplements for weight loss: a systematic review. Nutr Clin Pract 26, 539–552.
24.Camfield, DA, Sarris, J & Berk, M (2011) Nutraceuticals in the treatment of obsessive compulsive disorder (OCD): a review of mechanistic and clinical evidence. Prog Neuropsychopharmacol Biol Psychiatry 35, 887–895.
25.Goggs, R, Vaughan-Thomas, A, Clegg, PD, et al. (2005) Nutraceutical therapies for degenerative joint diseases: a critical review. Crit Rev Food Sci Nutr 45, 145–164.
26.Naveen, J & Baskaran, V (2018) Antidiabetic plant-derived nutraceuticals: a critical review. Eur J Nutr 57, 1275–1299.
27.Orr, SL & Venkateswaran, S (2014) Nutraceuticals in the prophylaxis of pediatric migraine: evidence-based review and recommendations. Cephalalgia 34, 568–583.
28.Orr, SL (2016) Diet and nutraceutical interventions for headache management: a review of the evidence. Cephalalgia 36, 1112–1133.
29.Tanret, C (1909) A new base taken from rye ergot, ergothioneine. Ann Chim Phys 18, 114–124.
30.Tanret, C (1909) The new base drawn from rye ergot, ergothioneine. Cr Hebd Acad Sci 149, 222–224.
31.Barger, G & Ewins, AJ (1911) The constitution of ergothioneine: a betaine related to histidine. J Chem Soc 99, 2336–2341.
32.Servillo, L, Castaldo, D, Casale, R, et al. (2015) An uncommon redox behavior sheds light on the cellular antioxidant properties of ergothioneine. Free Radic Biol Med 79, 228–236.
33.Franzoni, F, Colognato, R, Galetta, F, et al. (2006) An in vitro study on the free radical scavenging capacity of ergothioneine: comparison with reduced glutathione, uric acid and trolox. Biomed Pharmacother 60, 453–457.
34.Hand, CE, Taylor, NJ & Honek, JF (2005) Ab initio studies of the properties of intracellular thiols ergothioneine and ovothiol. Bioorg Med Chem Lett 15, 1357–1360.
35.Hand, CE & Honek, JF (2005) Biological chemistry of naturally occurring thiols of microbial and marine origin. J Nat Prod 68, 293–308.
36.Fahey, RC (2013) Glutathione analogs in prokaryotes. Biochim Biophys Acta 1830, 3182–3198.
37.Sheridan, KJ, Dolan, SK & Doyle, S (2015) Endogenous cross-talk of fungal metabolites. Front Microbiol 5, 732.
38.Fahey, RC (2001) Novel thiols of prokaryotes. Annu Rev Microbiol 55, 333–356.
39.Jacob, C (2006) A scent of therapy: pharmacological implications of natural products containing redox-active sulfur atoms. Nat Prod Rep 23, 851–863.
40.Clark, WM (1960) Oxidation-reduction Potentials of Organic Systems. Baltimore, MD: The Williams and Wilkins Co.
41.Walz, D (1979) Thermodynamics of oxidation–reduction reactions and its application to bioenergetics. Biochim Biophys Acta 505, 279–353.
42.Reyes, AM, Pedre, B, De Armas, MI, et al. (2018) Chemistry and redox biology of mycothiol. Antioxid Redox Signal 28, 487–504.
43.Sharma, SV, Van Laer, K, Messens, J, et al. (2016) Thiol redox and pKa properties of mycothiol, the predominant low-molecular-weight thiol cofactor in the actinomycetes. Chembiochemistry 17, 1689–1692.
44.Kell, DB & Morris, JG (1979) Oxidation–reduction properties of coenzyme M (2-mercaptoethane sulphonate) at the mercury electrode. FEBS Lett 108, 481–484.
45.Achouba, A, Dumas, P, Ouellet, N, et al. (2019) Selenoneine is a major selenium species in beluga skin and red blood cells of Inuit from Nunavik. Chemosphere 229, 549–558.
46.Little, M, Achouba, A, Dumas, P, et al. (2019) Determinants of selenoneine concentration in red blood cells of Inuit from Nunavik (Northern Quebec, Canada). Environ Int 127, 243–252.
47.Turrini, NG, Kroepfl, N, Jensen, KB, et al. (2018) Biosynthesis and isolation of selenoneine from genetically modified fission yeast. Metallomics 10, 1532–1538.
48.Rohn, I, Kroepfl, N, Bornhorst, J, et al. (2019) Side-directed transfer and presystemic metabolism of selenoneine in a human intestinal barrier model. Mol Nutr Food Res 63, e1900080.
49.Klein, M, Ouerdane, L, Bueno, M, et al. (2011) Identification in human urine and blood of a novel selenium metabolite, Se-methylselenoneine, a potential biomarker of metabolization in mammals of the naturally occurring selenoneine, by HPLC coupled to electrospray hybrid linear ion trap-orbital ion trap MS. Metallomics 3, 513–520.
50.Pluskal, T, Ueno, M & Yanagida, M (2014) Genetic and metabolomic dissection of the ergothioneine and selenoneine biosynthetic pathway in the fission yeast, S. pombe, and construction of an overproduction system. PLOS ONE 9, e97774.
51.Yamashita, Y & Yamashita, M (2010) Identification of a novel selenium-containing compound, selenoneine, as the predominant chemical form of organic selenium in the blood of bluefin tuna. J Biol Chem 285, 18134–18138.
52.Yamashita, Y, Yabu, T & Yamashita, M (2010) Discovery of the strong antioxidant selenoneine in tuna and selenium redox metabolism. World J Biol Chem 1, 144–150.
53.O’Hagan, S & Kell, DB (2017) Analysis of drug-endogenous human metabolite similarities in terms of their maximum common substructures. J Cheminform 9, 18.
54.O’Hagan, S & Kell, DB (2016) MetMaxStruct: a Tversky-similarity-based strategy for analysing the (sub)structural similarities of drugs and endogenous metabolites. Front Pharmacol 7, 266.
55.O’Hagan, S & Kell, DB (2015) The KNIME workflow environment and its applications in genetic programming and machine learning. Genetic Progr Evol Mach 16, 387–391.
56.Thiele, I, Swainston, N, Fleming, RMT, et al. (2013) A community-driven global reconstruction of human metabolism. Nat Biotechnol 31, 419–425.
57.O’Hagan, S, Swainston, N, Handl, J, et al. (2015) A ‘rule of 0.5’ for the metabolite-likeness of approved pharmaceutical drugs. Metabolomics 11, 323–339.
58.Lewis, KA, Tzilivakis, J, Warner, DJ, et al. (2016) An international database for pesticide risk assessments and management. Hum Ecol Risk Assess 22, 1050–1064.
59.Melville, DB, Genghof, DS, Inamine, E, et al. (1956) Ergothioneine in microorganisms. J Biol Chem 223, 9–17.
60.Jones, GW, Doyle, S & Fitzpatrick, DA (2014) The evolutionary history of the genes involved in the biosynthesis of the antioxidant ergothioneine. Gene 549, 161–170.
61.Newton, GL, Arnold, K, Price, MS, et al. (1996) Distribution of thiols in microorganisms: mycothiol is a major thiol in most actinomycetes. J Bacteriol 178, 1990–1995.
62.Dosanjh, M, Newton, GL & Davies, J (2008) Characterization of a mycothiol ligase mutant of Rhodococcus jostii RHA1. Res Microbiol 159, 643–650.
63.Genghof, DS & Van Damme, O (1964) Biosynthesis of ergothioneine and hercynine by mycobacteria. J Bacteriol 87, 852–862.
64.Genghof, DS & Van Damme, O (1968) Biosynthesis of ergothioneine from endogenous hercynine in Mycobacterium smegmatis. J Bacteriol 95, 340–344.
65.Genghof, DS (1970) Biosynthesis of ergothioneine and hercynine by fungi and Actinomycetales. J Bacteriol 103, 475–478.
66.Trivedi, A, Singh, N, Bhat, SA, et al. (2012) Redox biology of tuberculosis pathogenesis. Adv Microb Physiol 60, 263–324.
67.Narainsamy, K, Farci, S, Braun, E, et al. (2016) Oxidative-stress detoxification and signalling in cyanobacteria: the crucial glutathione synthesis pathway supports the production of ergothioneine and ophthalmate. Mol Microbiol 100, 15–24.
68.Baran, R, Bowen, BP, Price, MN, et al. (2013) Metabolic footprinting of mutant libraries to map metabolite utilization to genotype. ACS Chem Biol 8, 189–199.
69.Baran, R, Ivanova, NN, Jose, N, et al. (2013) Functional genomics of novel secondary metabolites from diverse cyanobacteria using untargeted metabolomics. Mar Drugs 11, 3617–3631.
70.Pfeiffer, C, Bauer, T, Surek, B, et al. (2011) Cyanobacteria produce high levels of ergothioneine. Food Chem 129, 1766–1769.
71.Liao, C & Seebeck, FP (2017) Convergent evolution of ergothioneine biosynthesis in cyanobacteria. Chembiochemistry 18, 2115–2118.
72.Alamgir, KM, Masuda, S, Fujitani, Y, et al. (2015) Production of ergothioneine by Methylobacterium species. Front Microbiol 6, 1185.
73.Rawat, M & Av-Gay, Y (2007) Mycothiol-dependent proteins in actinomycetes. FEMS Microbiol Rev 31, 278–292.
74.Melville, DB & Eich, S (1956) The occurrence of ergothioneine in plant material. J Biol Chem 218, 647–651.
75.Baran, R, Brodie, EL, Mayberry-Lewis, J, et al. (2015) Exometabolite niche partitioning among sympatric soil bacteria. Nat Commun 6, 8289.
76.Melville, DB (1959) Ergothioneine. Vitam Horm 17, 155–204.
77.Tan, CH & Audley, BG (1968) Ergothioneine and hercynine in Hevea brasiliensis latex. Phytochemistry 7, 109–118.
78.Audley, BG & Tan, CH (1968) Uptake of ergothioneine from soil into latex of Hevea brasiliensis. Phytochemistry 7, 1999–2000.
79.Warren, CR (2013) Quaternary ammonium compounds can be abundant in some soils and are taken up as intact molecules by plants. New Phytol 198, 476–485.
80.Park, EJ, Lee, WY, Kim, ST, et al. (2010) Ergothioneine accumulation in a medicinal plant Gastrodia elata. J Med Lant Res 4, 1141–1147.
81.Guo, QL, Lin, S, Wang, YN, et al. (2016) Gastrolatathioneine, an unusual ergothioneine derivative from an aqueous extract of “tian ma”: a natural product co-produced by plant and symbiotic fungus. Chin Chem Lett 27, 1577–1581.
82.Melville, DB, Otken, CC & Kovalenko, V (1955) On the origin of animal ergothioneine. J Biol Chem 216, 325–331.
83.Melville, DB, Horner, WH, Otken, CC, et al. (1955) Studies on the origin of ergothioneine in animals. J Biol Chem 213, 61–68.
84.Eagles, BA & Vars, HM (1928) The physiology of ergothioneine. J Biol Chem 80, 615–622.
85.Melville, DB, Horner, WH & Lubschez, R (1954) Tissue ergothioneine. J Biol Chem 206, 221–228.
86.Kawano, H, Otani, M, Takeyama, K, et al. (1982) Studies on ergothioneine. VI. Distribution and fluctuations of ergothioneine in rats. Chem Pharm Bull (Tokyo) 30, 1760–1765.
87.Tucker, RAJ, Cheah, IK & Halliwell, B (2019) Specificity of the ergothioneine transporter natively expressed in HeLa cells. Biochem Biophys Res Commun 513, 22–27.
88.Bu’Lock, JD (1961) Intermediary metabolism and antibiotic synthesis. Adv Microbial Physiol 3, 293–333.
89.Melville, DB, Eich, S & Ludwig, ML (1957) The biosynthesis of ergothioneine. J Biol Chem 224, 871–877.
90.Askari, A & Melville, DB (1962) The reaction sequence in ergothioneine biosynthesis: hercynine as an intermediate. J Biol Chem 237, 1615–1618.
91.Seebeck, FP (2013) Thiohistidine biosynthesis. Chimia (Aarau) 67, 333–336.
92.Seebeck, FP (2010) In vitro reconstitution of mycobacterial ergothioneine biosynthesis. J Am Chem Soc 132, 6632–6633.
93.Richard-Greenblatt, M, Bach, H, Adamson, J, et al. (2015) Regulation of ergothioneine biosynthesis and its effect on Mycobacterium tuberculosis growth and infectivity. J Biol Chem 290, 23064–23076.
94.Naowarojna, N, Cheng, R, Chen, L, et al. (2018) Mini-review: ergothioneine and ovothiol biosyntheses, an unprecedented trans-sulfur strategy in natural product biosynthesis. Biochemistry 57, 3309–3325.
95.Reinhold, VN, Ishikawa, Y & Melville, DB (1970) Conversion of histidine to hercynine by Neurospora crassa. J Bacteriol 101, 881–884.
96.Melville, DB, Ludwig, ML, Inamine, E, et al. (1959) Transmethylation in the biosynthesis of ergothioneine. J Biol Chem 234, 1195–1198.
97.Ishikawa, Y, Israel, SE & Melville, DB (1974) Participation of an intermediate sulfoxide in the enzymatic thiolation of the imidazole ring of hercynine to form ergothioneine. J Biol Chem 249, 4420–4427.
98.Leisinger, F, Burn, R, Meury, M, et al. (2019) Structural and mechanistic basis for anaerobic ergothioneine biosynthesis. J Am Chem Soc 141, 6906–6914.
99.Burn, R, Misson, L, Meury, M, et al. (2017) Anaerobic origin of ergothioneine. Angew Chem Int Ed Engl 56, 12508–12511.
100.Ruszczycky, MW & Liu, HW (2017) The surprising history of an antioxidant. Nature 551, 37–38.
101.Goncharenko, KV, Vit, A, Blankenfeldt, W, et al. (2015) Structure of the sulfoxide synthase EgtB from the ergothioneine biosynthetic pathway. Angew Chem Int Ed Engl 54, 2821–2824.
102.Vit, A, Mashabela, GT, Blankenfeldt, W, et al. (2015) Structure of the ergothioneine-biosynthesis amidohydrolase EgtC. ChemBioChem 16, 1490–1496.
103.Vit, A, Misson, L, Blankenfeldt, W, et al. (2014) Crystallization and preliminary X-ray analysis of the ergothioneine-biosynthetic methyltransferase EgtD. Acta Crystallogr F Struct Biol Commun 70, 676–680.
104.Vit, A, Misson, L, Blankenfeldt, W, et al. (2015) Ergothioneine biosynthetic methyltransferase EgtD reveals the structural basis of aromatic amino acid betaine biosynthesis. ChemBioChem 16, 119–125.
105.Misson, L, Burn, R, Vit, A, et al. (2018) Inhibition and regulation of the ergothioneine biosynthetic methyltransferase EgtD. ACS Chem Biol 13, 1333–1342.
106.Irani, S, Naowarojna, N, Tang, Y, et al. (2018) Snapshots of C-S cleavage in Egt2 reveals substrate specificity and reaction mechanism. Cell Chem Biol 25, 519–529.e514.
107.Naowarojna, N, Irani, S, Hu, WY, et al. (2019) Crystal structure of the ergothioneine sulfoxide synthase from Candidatus Chloracidobacterium thermophilum and structure-guided engineering to modulate its substrate selectivity. ACS Catal 9, 6955–6961.
110.Daunay, S, Lebel, R, Farescour, L, et al. (2016) Short protecting-group-free synthesis of 5-acetylsulfanyl-histidines in water: novel precursors of 5-sulfanyl-histidine and its analogues. Org Biomol Chem 14, 10473–10480.
111.Xu, JZ & Yadan, JC (1995) Synthesis of l-(+)-ergothioneine. J Org Chem 60, 6296–6301.
112.Khonde, PL & Jardine, A (2015) Improved synthesis of the super antioxidant, ergothioneine, and its biosynthetic pathway intermediates. Org Biomol Chem 13, 1415–1419.
113.Fujitani, Y, Alamgir, KM & Tani, A (2018) Ergothioneine production using Methylobacterium species, yeast, and fungi. J Biosci Bioeng 126, 715–722.
114.Takusagawa, S, Satoh, Y, Ohtsu, I, et al. (2019) Ergothioneine production with Aspergillus oryzae. Biosci Biotechnol Biochem 83, 181–184.
115.Osawa, R, Kamide, T, Satoh, Y, et al. (2018) Heterologous and high production of ergothioneine in Escherichia coli. J Agric Food Chem 66, 1191–1196.
116.Tanaka, N, Kawano, Y, Satoh, Y, et al. (2019) Gram-scale fermentative production of ergothioneine driven by overproduction of cysteine in Escherichia coli. Sci Rep 9, 1895.
117.van der Hoek, SA, Darbani, B, Zugaj, K, et al. (2019) Engineering the yeast Saccharomyces cerevisiae for the production of l-(+)-ergothioneine. Front Bioeng Biotechnol 7, 262.
118.Li, M & Borodina, I (2015) Application of synthetic biology for production of chemicals in yeast Saccharomyces cerevisiae. FEMS Yeast Res 15, 1–12.
119.O’Hagan, S, Wright Muelas, M, Day, PJ, et al. (2018) GeneGini: assessment via the Gini coefficient of reference “housekeeping” genes and diverse human transporter expression profiles. Cell Syst 6, 230–244.
120.Chaleckis, R, Ebe, M, Pluskal, T, et al. (2014) Unexpected similarities between the Schizosaccharomyces and human blood metabolomes, and novel human metabolites. Mol Biosyst 10, 2538–2551.
121.McMenamy, RH, Lund, CC & Wallach, DF (1960) Unbound amino acid concentrations in plasma, erythrocytes, leukocytes and urine of patients with leukemia. J Clin Invest 39, 1688–1705.
122.McMenamy, RH, Lund, CC, Neville, GJ, et al. (1960) Studies of unbound amino acid distributions in plasma, erythrocytes, leukocytes and urine of normal human subjects. J Clin Invest 39, 1675–1687.
123.Arduini, A, Mancinelli, G, Radatti, GL, et al. (1992) Possible mechanism of inhibition of nitrite-induced oxidation of oxyhemoglobin by ergothioneine and uric acid. Arch Biochem Biophys 294, 398–402.
124.Li, RWS, Yang, C, Sit, ASM, et al. (2014) Uptake and protective effects of ergothioneine in human endothelial cells. J Pharmacol Exp Ther 350, 691–700.
125.Weigand-Heller, AJ, Kris-Etherton, PM & Beelman, RB (2012) The bioavailability of ergothioneine from mushrooms (Agaricus bisporus) and the acute effects on antioxidant capacity and biomarkers of inflammation. Prev Med 54, Suppl., S75–S78.
126.Reglinski, J, Smith, WE, Wilson, R, et al. (1991) Clinical analysis in intact erythrocytes using 1H spin echo NMR. Clin Chim Acta 201, 45–57.
127.Wang, LZ, Thuya, WL, Toh, DS, et al. (2013) Quantification of l-ergothioneine in human plasma and erythrocytes by liquid chromatography–tandem mass spectrometry. J Mass Spectrom 48, 406–412.
128.Turner, E, Brewster, JA, Simpson, NA, et al. (2009) Imidazole-based erythrocyte markers of oxidative stress in preeclampsia – an NMR investigation. Reprod Sci 16, 1040–1051.
129.Mitsuyama, H & May, JM (1999) Uptake and antioxidant effects of ergothioneine in human erythrocytes. Clin Sci (Lond) 97, 407–411.
130.Gründemann, D, Harlfinger, S, Golz, S, et al. (2005) Discovery of the ergothioneine transporter. Proc Natl Acad Sci U S A 102, 5256–5261.
131.Tang, RMY, Cheah, IK, Yew, TSK, et al. (2018) Distribution and accumulation of dietary ergothioneine and its metabolites in mouse tissues. Sci Rep 8, 1601.
132.Nikodemus, D, Lazic, D, Bach, M, et al. (2011) Paramount levels of ergothioneine transporter SLC22A4 mRNA in boar seminal vesicles and cross-species analysis of ergothioneine and glutathione in seminal plasma. J Physiol Pharmacol 62, 411–419.
133.Kaneko, I, Takeuchi, Y, Yamaoka, Y, et al. (1980) Quantitative determination of ergothioneine in plasma and tissues by TLC-densitometry. Chem Pharm Bull (Tokyo) 28, 3093–3097.
134.Shires, TK, Brummel, MC, Pulido, JS, et al. (1997) Ergothioneine distribution in bovine and porcine ocular tissues. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 117, 117–120.
135.Crossland, J, Mitchell, J & Woodruff, GN (1966) The presence of ergothioneine in the central nervous system and its probable identity with the cerebellar factor. J Physiol 182, 427–438.
136.Nakamichi, N, Taguchi, T, Hosotani, H, et al. (2012) Functional expression of carnitine/organic cation transporter OCTN1 in mouse brain neurons: possible involvement in neuronal differentiation. Neurochem Int 61, 1121–1132.
137.Vermeulen, E & Vermeersch, P (2012) Hepcidin as a biomarker for the diagnosis of iron metabolism disorders: a review. Acta Clin Belg 67, 190–197.
138.Ganz, T & Nemeth, E (2011) The hepcidin–ferroportin system as a therapeutic target in anemias and iron overload disorders. Hematol Am Soc Hematol Educ Program 2011, 538–542.
139.Ganz, T & Nemeth, E (2012) Hepcidin and iron homeostasis. Biochim Biophys Acta 1823, 1434–1443.
140.Nemeth, E & Ganz, T (2009) The role of hepcidin in iron metabolism. Acta Haematol 122, 78–86.
141.Reichert, CO, da Cunha, J, Levy, D, et al. (2017) Hepcidin: homeostasis and diseases related to iron metabolism. Acta Haematol 137, 220–236.
142.Kell, DB, Swainston, N, Pir, P, et al. (2015) Membrane transporter engineering in industrial biotechnology and whole-cell biocatalysis. Trends Biotechnol 33, 237–246.
143.Dobson, PD & Kell, DB (2008) Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? Nat Rev Drug Disc 7, 205–220.
144.Kell, DB & Dobson, PD (2009) The cellular uptake of pharmaceutical drugs is mainly carrier-mediated and is thus an issue not so much of biophysics but of systems biology. In Proceedings of the International Beilstein Symposium on Systems Chemistry, pp. 149–168 [Hicks, MG and Kettner, C, editors]. Berlin: Logos Verlag.
145.Kell, DB, Dobson, PD & Oliver, SG (2011) Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only. Drug Disc Today 16, 704–714.
146.Kell, DB, Dobson, PD, Bilsland, E, et al. (2013) The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so. Drug Disc Today 18, 218–239.
147.Kell, DB (2013) Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening, and knowledge of transporters: where drug discovery went wrong and how to fix it. FEBS J 280, 5957–5980.
148.Kell, DB & Oliver, SG (2014) How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion. Front Pharmacol 5, 231.
149.Kell, DB (2015) The transporter-mediated cellular uptake of pharmaceutical drugs is based on their metabolite-likeness and not on their bulk biophysical properties: towards a systems pharmacology. Perspect Sci 6, 66–83.
150.Kell, DB (2016) How drugs pass through biological cell membranes – a paradigm shift in our understanding? Beilstein Magazine 2, no. 5.
151.Giacomini, KM, Huang, SM, Tweedie, DJ, et al. (2010) Membrane transporters in drug development. Nat Rev Drug Discov 9, 215–236.
152.Dickens, D, Rädisch, S, Chiduza, GN, et al. (2018) Cellular uptake of the atypical antipsychotic clozapine is a carrier-mediated process. Mol Pharm 15, 3557–3572.
153.César-Razquin, A, Snijder, B, Frappier-Brinton, T, et al. (2015) A call for systematic research on solute carriers. Cell 162, 478–487.
154.Hediger, MA, Clemencon, B, Burrier, RE, et al. (2013) The ABCs of membrane transporters in health and disease (SLC series): Introduction. Mol Aspects Med 34, 95–107.
156.Chen, Z, Shi, T, Zhang, L, et al. (2016) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade. Cancer Lett 370, 153–164.
157.Koepsell, H (2013) The SLC22 family with transporters of organic cations, anions and zwitterions. Mol Aspects Med 34, 413–435.
158.Pochini, L, Galluccio, M, Scalise, M, et al. (2019) OCTN: a small transporter subfamily with great relevance to human pathophysiology, drug discovery, and diagnostics. SLAS Discov 24, 89–110.
159.Garg, N, Kapono, C, Lim, YW, et al. (2015) Mass spectral similarity for untargeted metabolomics data analysis of complex mixtures. Int J Mass Spectrom 377, 719–717.
160.Li, XS, Wang, Z, Cajka, T, et al. (2018) Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk. JCI Insight 3, 99096.
161.Coene, KLM, Kluijtmans, LAJ, van der Heeft, E, et al. (2018) Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients. J Inherit Metab Dis 41, 337–353.
162.Tautenhahn, R, Cho, K, Uritboonthai, W, et al. (2012) An accelerated workflow for untargeted metabolomics using the METLIN database. Nature Biotechnol 30, 826–828.
163.Dunn, WB, Broadhurst, D, Begley, P, et al. (2011) Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 6, 1060–1083.
164.Dunn, WB, Erban, A, Weber, RJM, et al. (2013) Mass appeal: metabolite identification in mass spectrometry-focused untargeted metabolomics. Metabolomics 9, Suppl. 1, S44–S66.
165.Heinzmann, SS, Brown, IJ, Chan, Q, et al. (2010) Metabolic profiling strategy for discovery of nutritional biomarkers: proline betaine as a marker of citrus consumption. Am J Clin Nutr 92, 436–443.
166.Lang, R, Lang, T, Bader, M, et al. (2017) High-throughput quantitation of proline betaine in foods and suitability as a valid biomarker for citrus consumption. J Agric Food Chem 65, 1613–1619.
167.Lloyd, AJ, Beckmann, M, Favé, G, et al. (2011) Proline betaine and its biotransformation products in fasting urine samples are potential biomarkers of habitual citrus fruit consumption. Br J Nutr 106, 812–824.
168.Gasteiger, J (2003) Basic Chemoinformatics: A Textbook. Weinheim: Wiley/VCH.
169.Bacher, P, Giersiefer, S, Bach, M, et al. (2009) Substrate discrimination by ergothioneine transporter SLC22A4 and carnitine transporter SLC22A5: gain-of-function by interchange of selected amino acids. Biochim Biophys Acta 1788, 2594–2602.
170.Grigat, S, Harlfinger, S, Pal, S, et al. (2007) Probing the substrate specificity of the ergothioneine transporter with methimazole, hercynine, and organic cations. Biochem Pharmacol 74, 309–316.
171.Gründemann, D (2012) The ergothioneine transporter controls and indicates ergothioneine activity – a review. Prev Med 54, Suppl., S71–S74.
172.Tschirka, J, Kreisor, M, Betz, J, et al. (2018) Substrate selectivity check of the ergothioneine transporter. Drug Metab Dispos 46, 779–785.
173.Shimizu, T, Masuo, Y, Takahashi, S, et al. (2015) Organic cation transporter OCTN1-mediated uptake of food-derived antioxidant ergothioneine into infiltrating macrophages during intestinal inflammation in mice. Drug Metab Pharmacokinet 30, 231–239.
174.Yabuuchi, H, Tamai, I, Nezu, J, et al. (1999) Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther 289, 768–773.
175.Akamine, T, Koyanagi, S, Kusunose, N, et al. (2015) Dosing time-dependent changes in the analgesic effect of pregabalin on diabetic neuropathy in mice. J Pharmacol Exp Ther 354, 65–72.
176.Shimizu, T, Kijima, A, Masuo, Y, et al. (2015) Gene ablation of carnitine/organic cation transporter 1 reduces gastrointestinal absorption of 5-aminosalicylate in mice. Biol Pharm Bull 38, 774–780.
177.Tamai, I (2013) Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21). Biopharm Drug Dispos 34, 29–44.
178.Nakamura, T, Yoshida, K, Yabuuchi, H, et al. (2008) Functional characterization of ergothioneine transport by rat organic cation/carnitine transporter OCTN1 (SLC22A4). Biol Pharm Bull 31, 1580–1584.
179.Darghouth, D, Giarratana, MC, Oliveira, L, et al. (2016) Bio-engineered and native red blood cells from cord blood exhibit the same metabolomic profile. Haematologica 101, e220–e222.
180.Taubert, D, Lazar, A, Grimberg, G, et al. (2006) Association of rheumatoid arthritis with ergothioneine levels in red blood cells: a case control study. J Rheumatol 33, 2139–2145.
181.Indiveri, C, Galluccio, M, Scalise, M, et al. (2013) Strategies of bacterial over expression of membrane transporters relevant in human health: the successful case of the three members of OCTN subfamily. Mol Biotechnol 54, 724–736.
182.Frigeni, M, Iacobazzi, F, Yin, X, et al. (2016) Wide tolerance to amino acids substitutions in the OCTN1 ergothioneine transporter. Biochim Biophys Acta 1860, 1334–1342.
183.Nigam, SK (2018) The SLC22 transporter family: a paradigm for the impact of drug transporters on metabolic pathways, signaling, and disease. Annu Rev Pharmacol Toxicol 58, 663–687.
184.Pochini, L, Scalise, M, Galluccio, M, et al. (2013) OCTN cation transporters in health and disease: role as drug targets and assay development. J Biomol Screen 18, 851–867.
185.Wolf, KK & Paine, MF (2018) Metabolic barrier of the gastrointestinal tract. In Comprehensive Toxicology, 3rd ed., pp. 74–98 [McQueen, C, editor]. Amsterdam: Elsevier.
186.Thul, PJ, Åkesson, L, Wiking, M, et al. (2017) A subcellular map of the human proteome. Science 356, eaal3321.
187.Apostolova, N & Victor, VM (2015) Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications. Antioxid Redox Signal 22, 686–729.
188.Lamhonwah, AM & Tein, I (2006) Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria. Biochem Biophys Res Commun 345, 1315–1325.
189.Lamhonwah, AM, Hawkins, CE, Tam, C, et al. (2008) Expression patterns of the organic cation/carnitine transporter family in adult murine brain. Brain Dev 30, 31–42.
190.Xuan, W, Lamhonwah, AM, Librach, C, et al. (2003) Characterization of organic cation/carnitine transporter family in human sperm. Biochem Biophys Res Commun 306, 121–128.
192.Skogs, M, Stadler, C, Schutten, R, et al. (2017) Antibody validation in bioimaging applications based on endogenous expression of tagged proteins. J Proteome Res 16, 147–155.
193.Edfors, F, Hober, A, Linderbäck, K, et al. (2018) Enhanced validation of antibodies for research applications. Nat Commun 9, 4130.
194.Rabia, LA, Desai, AA, Jhajj, HS, et al. (2018) Understanding and overcoming trade-offs between antibody affinity, specificity, stability and solubility. Biochem Eng J 137, 365–374.
195.Jain, D & Salunke, DM (2019) Antibody specificity and promiscuity. Biochem J 476, 433–447.
196.Edwards, BM, Barash, SC, Main, SH, et al. (2003) The remarkable flexibility of the human antibody repertoire; isolation of over one thousand different antibodies to a single protein, BLyS. J Mol Biol 334, 103–118.
197.Vaughan, TJ, Osbourn, JK & Tempest, PR (1998) Human antibodies by design. Nat Biotechnol 16, 535–539.
198.Michaud, GA, Salcius, M, Zhou, F, et al. (2003) Analyzing antibody specificity with whole proteome microarrays. Nat Biotechnol 21, 1509–1512.
199.Palmieri, F (2013) The mitochondrial transporter family SLC25: identification, properties and physiopathology. Mol Aspects Med 34, 465–484.
200.Palmieri, F (2014) Mitochondrial transporters of the SLC25 family and associated diseases: a review. J Inherit Metab Dis 37, 565–575.
203.O’Hagan, S & Kell, DB (2017) Consensus rank orderings of molecular fingerprints illustrate the ‘most genuine’ similarities between marketed drugs and small endogenous human metabolites, but highlight exogenous natural products as the most important ‘natural’ drug transporter substrates. ADMET DMPK 5, 85–125.
204.Chapy, H, Smirnova, M, Andre, P, et al. (2014) Carrier-mediated cocaine transport at the blood–brain barrier as a putative mechanism in addiction liability. Int J Neuropsychopharmacol 18, pyu001.
205.Danchin, A (2018) Bacteria in the ageing gut: did the taming of fire promote a long human lifespan? Environ Microbiol 20, 1966–1987.
206.Kell, DB & Pretorius, E (2018) No effects without causes. The iron dysregulation and dormant microbes hypothesis for chronic, inflammatory diseases. Biol Rev 93, 1518–1557.
207.Butterfield, DA & Halliwell, B (2019) Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci 20, 148–160.
208.Kell, DB (2009) Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics 2, 2.
209.Babior, BM (2000) Phagocytes and oxidative stress. Am J Med 109, 33–44.
210.Cave, AC, Brewer, AC, Narayanapanicker, A, et al. (2006) NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 8, 691–728.
211.Bedard, K & Krause, KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87, 245–313.
212.Wardman, P & Candeias, LP (1996) Fenton chemistry: an introduction. Rad Res 145, 523–531.
213.Kell, DB (2010) Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples. Arch Toxicol 577, 825–889.
214.Winston, GW, Feierman, DE & Cederbaum, AI (1984) The role of iron chelates in hydroxyl radical production by rat liver microsomes, NADPH-cytochrome P-450 reductase and xanthine oxidase. Arch Biochem Biophys 232, 378–390.
215.Fong, A & Hieftje, GM (1995) Near-IR multiplex bandpass spectrometer utilizing liquid molecular filters. Appl Spectrosc 49, 493–498.
216.Kehrer, JP (2000) The Haber–Weiss reaction and mechanisms of toxicity. Toxicology 149, 43–50.
217.Kell, DB & Pretorius, E (2014) Serum ferritin is an important disease marker, and is mainly a leakage product from damaged cells. Metallomics 6, 748–773.
218.Valachová, K, Mach, M, Dubovický, M, et al. (2019) The importance of ergothioneine synthesis in ancient time by organisms living in oxygen free atmosphere. Med Hypotheses 123, 72–73.
219.Migliore, L, Fontana, I, Colognato, R, et al. (2005) Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer’s disease and in other neurodegenerative diseases. Neurobiol Aging 26, 587–595.
220.Ahsan, H (2013) 3-Nitrotyrosine: a biomarker of nitrogen free radical species modified proteins in systemic autoimmunogenic conditions. Hum Immunol 74, 1392–1399.
221.Bartesaghi, S & Radi, R (2018) Fundamentals on the biochemistry of peroxynitrite and protein tyrosine nitration. Redox Biol 14, 618–625.
222.Ryberg, H & Caidahl, K (2007) Chromatographic and mass spectrometric methods for quantitative determination of 3-nitrotyrosine in biological samples and their application to human samples. J Chromatogr B 851, 160–171.
223.Rahman, I (2012) Pharmacological antioxidant strategies as therapeutic interventions for COPD. Biochim Biophys Acta 1822, 714–728.
224.Aruoma, OI, Whiteman, M, England, TG, et al. (1997) Antioxidant action of ergothioneine: assessment of its ability to scavenge peroxynitrite. Biochem Biophys Res Commun 231, 389–391.
225.Halliwell, B (1997) What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett 411, 157–160.
226.Ferrer-Sueta, G, Campolo, N, Trujillo, M, et al. (2018) Biochemistry of peroxynitrite and protein tyrosine nitration. Chem Rev 118, 1338–1408.
227.Petersen, DR & Doorn, JA (2004) Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic Biol Med 37, 937–945.
228.Akanmu, D, Cecchini, R, Aruoma, OI, et al. (1991) The antioxidant action of ergothioneine. Arch Biochem Biophys 288, 10–16.
229.Asmus, KD, Bensasson, RV, Bernier, JL, et al. (1996) One-electron oxidation of ergothioneine and analogues investigated by pulse radiolysis: redox reaction involving ergothioneine and vitamin C. Biochem J 315, 625–629.
230.Motohashi, N & Mori, I (1986) Thiol-induced hydroxyl radical formation and scavenger effect of thiocarbamides on hydroxyl radicals. J Inorg Biochem 26, 205–212.
231.Jang, JH, Aruoma, OI, Jen, LS, et al. (2004) Ergothioneine rescues PC12 cells from β-amyloid-induced apoptotic death. Free Radic Biol Med 36, 288–299.
232.Chaudière, J & Ferrari-Iliou, R (1999) Intracellular antioxidants: from chemical to biochemical mechanisms. Food Chem Toxicol 37, 949–962.
233.Oumari, M, Goldfuss, B, Stoffels, C, et al. (2019) Regeneration of ergothioneine after reaction with singlet oxygen. Free Radic Biol Med 134, 498–504.
234.Devasagayam, TPA, Sundquist, AR, Di Mascio, P, et al. (1991) Activity of thiols as singlet molecular oxygen quenchers. J Photochem Photobiol B 9, 105–116.
235.Hartman, PE, Hartman, Z & Ault, KT (1990) Scavenging of singlet molecular oxygen by imidazole compounds: high and sustained activities of carboxy terminal histidine dipeptides and exceptional activity of imidazole-4-acetic acid. Photochem Photobiol 51, 59–66.
236.van den Broeke, LT & Beyersbergen van Henegouwen, GM (1993) Thiols as potential UV radiation protectors: an in vitro study. J Photochem Photobiol B 17, 279–286.
237.Egorov, S, Kurella, EG, Boldyrev, AA, et al. (1997) Quenching of singlet molecular oxygen by carnosine and related antioxidants. Monitoring 1270-nm phosphorescence in aqueous media. Biochem Mol Biol Int 41, 687–694.
238.Boldyrev, A & Abe, H (1999) Metabolic transformation of neuropeptide carnosine modifies its biological activity. Cell Mol Neurobiol 19, 163–175.
239.Dahl, TA, Midden, WR & Hartman, PE (1988) Some prevalent biomolecules as defenses against singlet oxygen damage. Photochem Photobiol 47, 357–362.
240.Dong, KK, Damaghi, N, Kibitel, J, et al. (2007) A comparison of the relative antioxidant potency of l-ergothioneine and idebenone. J Cosmet Dermatol 6, 183–188.
241.Obayashi, K, Kurihara, K, Okano, Y, et al. (2005) l-Ergothioneine scavenges superoxide and singlet oxygen and suppresses TNF-α and MMP-1 expression in UV-irradiated human dermal fibroblasts. J Cosmet Sci 56, 17–27.
242.Stoffels, C, Oumari, M, Perrou, A, et al. (2017) Ergothioneine stands out from hercynine in the reaction with singlet oxygen: resistance to glutathione and TRIS in the generation of specific products indicates high reactivity. Free Radic Biol Med 113, 385–394.
243.He, QC, Krone, K, Scherl, D, et al. (2004) The use of ozone as an oxidizing agent to evaluate antioxidant activities of natural substrates. Skin Pharmacol Physiol 17, 183–189.
244.Markova, NG, Karaman-Jurukovska, N, Dong, KK, et al. (2009) Skin cells and tissue are capable of using l-ergothioneine as an integral component of their antioxidant defense system. Free Radic Biol Med 46, 1168–1176.
245.Nguyen, TH, Nagasaka, R & Ohshima, T (2013) The natural antioxidant ergothioneine: resources, chemical characterization, and applications. In Lipid Oxidation: Challenges in Food Systems, pp. 381–415 [Logan, A, Nienaber, U and Pan, X, editors]. Urbana, IL: AOCS Press.
246.Servillo, L, D’Onofrio, N, Casale, R, et al. (2017) Ergothioneine products derived by superoxide oxidation in endothelial cells exposed to high-glucose. Free Radic Biol Med 108, 8–18.
247.Bello, MH, Barrera-Perez, V, Morin, D, et al. (2012) The Neurospora crassa mutant NcΔEgt-1 identifies an ergothioneine biosynthetic gene and demonstrates that ergothioneine enhances conidial survival and protects against peroxide toxicity during conidial germination. Fungal Genet Biol 49, 160–172.
248.Hartman, PE (1990) Ergothioneine as antioxidant. Meth Enzymol 186, 310–318.
249.Asahi, T, Wu, X, Shimoda, H, et al. (2016) A mushroom-derived amino acid, ergothioneine, is a potential inhibitor of inflammation-related DNA halogenation. Biosci Biotechnol Biochem 80, 313–317.
250.Whiteman, M & Halliwell, B (1997) Thiols and disulphides can aggravate peroxynitrite-dependent inactivation of α1-antiproteinase. FEBS Lett 414, 497–500.
251.Aruoma, OI, Spencer, JPE & Mahmood, N (1999) Protection against oxidative damage and cell death by the natural antioxidant ergothioneine. Food Chem Toxicol 37, 1043–1053.
252.Garay, AS (1956) On the effect of some protective and stimulatory substances in honey-dew on the germination of ergot conidia. Physiol Plantarum 9, 344–349.
253.Garay, AS (1956) Role of ergothioneine and catalase in infection by ergot fungus (Claviceps purpurea Tul.). Nature 177, 91–92.
254.Sao Emani, C, Williams, MJ, Wiid, IJ, et al. (2013) Ergothioneine is a secreted antioxidant in Mycobacterium smegmatis. Antimicrob Agents Chemother 57, 3202–3207.
255.Nakajima, S, Satoh, Y, Yanashima, K, et al. (2015) Ergothioneine protects Streptomyces coelicolor A3(2) from oxidative stresses. J Biosci Bioeng 120, 294–298.
256.Liu, H, Zhao, X, Guo, M, et al. (2015) Growth and metabolism of Beauveria bassiana spores and mycelia. BMC Microbiol 15, 267.
257.Sheridan, KJ, Lechner, BE, Keeffe, GO, et al. (2016) Ergothioneine biosynthesis and functionality in the opportunistic fungal pathogen, Aspergillus fumigatus. Sci Rep 6, 35306.
258.Ta, P, Buchmeier, N, Newton, GL, et al. (2011) Organic hydroperoxide resistance protein and ergothioneine compensate for loss of mycothiol in Mycobacterium smegmatis mutants. J Bacteriol 193, 1981–1990.
259.Cumming, BM, Lamprecht, DA, Wells, RM, et al. (2014) The physiology and genetics of oxidative stress in mycobacteria. Microbiol Spectr 2 (epublication 2 May 2014).
260.Cumming, BM, Chinta, KC, Reddy, VP, et al. (2018) Role of ergothioneine in microbial physiology and pathogenesis. Antioxid Redox Signal 28, 431–444.
261.Farhana, A, Guidry, L, Srivastava, A, et al. (2010) Reductive stress in microbes: implications for understanding Mycobacterium tuberculosis disease and persistence. Adv Microb Physiol 57, 43–117.
262.Kurutas, EB (2016) The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutr J 15, 71.
263.Cardoso, SM (2019) Special issue: the antioxidant capacities of natural products. Molecules 24, 492–495.
264.Ooi, BK, Chan, K-G, Goh, BH, et al. (2018) The role of natural products in targeting cardiovascular diseases via Nrf2 pathway: novel molecular mechanisms and therapeutic approaches. Front Pharmacol 9, 1308.
265.Urquiaga, I & Leighton, F (2000) Plant polyphenol antioxidants and oxidative stress. Biol Res 33, 55–64.
266.Chen, W, Jia, Z, Pan, MH, et al. (2016) Natural products for the prevention of oxidative stress-related diseases: mechanisms and strategies. Oxid Med Cell Longev 2016, 4628502.
267.Salehi, B, Stojanović-Radić, Z, Matejić, J, et al. (2019) The therapeutic potential of curcumin: a review of clinical trials. Eur J Med Chem 163, 527–545.
268.Gonçalves, PB, Romeiro, NC (2019) Multi-target natural products as alternatives against oxidative stress in chronic obstructive pulmonary disease (COPD). Eur J Med Chem 163, 911–931.
269.Jia, ZQ, Anandh Babu, PV, Chen, W, et al. (2018) Natural products targeting on oxidative stress and inflammation: mechanisms, therapies, and safety assessment. Oxid Med Cell Longev 2018, 6576093.
270.Davey, HM & Kell, DB (1996) Flow cytometry and cell sorting of heterogeneous microbial populations: the importance of single-cell analysis. Microbiol Rev 60, 641–696.
271.Savoie, J-M, Minvielle, N & Largeteau, ML (2008) Radical-scavenging properties of extracts from the white button mushroom, Agaricus bisporus. J Sci Food Agric 88, 870–875.
272.Yokota, ME, Frison, PS, Marcante, RC, et al. (2016) Iron translocation in Pleurotus ostreatus basidiocarps: production, bioavailability, and antioxidant activity. Genet Mol Res 15.
273.Kozarski, M, Klaus, A, Jakovljevic, D, et al. (2015) Antioxidants of edible mushrooms. Molecules 20, 19489–19525.
274.Zhao, H, Zhang, M, Liu, Q, et al. (2018) A comprehensive screening shows that ergothioneine is the most abundant antioxidant in the wild macrofungus Phylloporia ribis Ryvarden. J Environ Sci Health C 36, 98–111.
275.Dubost, NJ, Ou, B & Beelman, RB (2007) Quantification of polyphenols and ergothioneine in cultivated mushrooms and correlation to total antioxidant capacity. Food Chem 105, 727–735.
276.Liao, WC, Wu, WH, Tsai, PC, et al. (2012) Kinetics of ergothioneine inhibition of mushroom tyrosinase. Appl Biochem Biotechnol 166, 259–267.
277.Kell, DB, Kaprelyants, AS & Grafen, A (1995) On pheromones, social behaviour and the functions of secondary metabolism in bacteria. Trends Ecol Evolution 10, 126–129.
278.Gallagher, L, Owens, RA, Dolan, SK, et al. (2012) The Aspergillus fumigatus protein GliK protects against oxidative stress and is essential for gliotoxin biosynthesis. Eukaryot Cell 11, 1226–1238.
279.Song, H, Her, AS, Raso, F, et al. (2014) Cysteine oxidation reactions catalyzed by a mononuclear non-heme iron enzyme (OvoA) in ovothiol biosynthesis. Org Lett 16, 2122–2125.
280.Castellano, I & Seebeck, FP (2018) On ovothiol biosynthesis and biological roles: from life in the ocean to therapeutic potential. Nat Prod Rep 35, 1241–1250.
281.Vázquez-Fresno, R, Rosana, ARR, Sajed, T, et al. (2019) Herbs and spices- biomarkers of intake based on human intervention studies – a systematic review. Genes Nutr 14, 18.
282.Menon, VP & Sudheer, AR (2007) Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol 595, 105–125.
283.Abrahams, S, Haylett, WL, Johnson, G, et al. (2019) Antioxidant effects of curcumin in models of neurodegeneration, aging, oxidative and nitrosative stress: a review. Neuroscience 406, 1–21.
284.Li, H, Sureda, A, Devkota, HP, et al. (2019) Curcumin, the golden spice in treating cardiovascular diseases. Biotechnol Adv 2019, S0734-9750(19)30010-2 (epublication ahead of print version 1 February 2019).
285.Sanei, M & Saberi-Demneh, A (2019) Effect of curcumin on memory impairment: a systematic review. Phytomedicine 52, 98–106.
286.Tomeh, MA, Hadianamrei, R & Zhao, X (2019) A review of curcumin and its derivatives as anticancer agents. Int J Mol Sci 20, E1033.
287.Pekkinen, J, Rosa-Sibakov, N, Micard, V, et al. (2015) Amino acid-derived betaines dominate as urinary markers for rye bran intake in mice fed high-fat diet – a nontargeted metabolomics study. Mol Nutr Food Res 59, 1550–1562.
288.Kempf, B & Bremer, E (1998) Uptake and synthesis of compatible solutes as microbial stress responses to high-osmolality environments. Arch Microbiol 170, 319–330.
289.Roberts, MF (2005) Organic compatible solutes of halotolerant and halophilic microorganisms. Saline Systems 1, 5.
290.Wani, SH, Singh, NB, Haribhushan, A, et al. (2013) Compatible solute engineering in plants for abiotic stress tolerance – role of glycine betaine. Curr Genomics 14, 157–165.
291.Weinand, M, Krämer, R, Morbach, S (2007) Characterization of compatible solute transporter multiplicity in Corynebacterium glutamicum. Appl Microbiol Biotechnol 76, 701–708.
292.Imhoff, JF & Rodriguez-Valera, F (1984) Betaine is the main compatible solute of halophilic eubacteria. Bacteriology 160, 478–479.
293.Fahnert, B (2012) Using folding promoting agents in recombinant protein production: a review. Methods Mol Biol 824, 3–36.
294.Ey, J, Schömig, E & Taubert, D (2007) Dietary sources and antioxidant effects of ergothioneine. J Agric Food Chem 55, 6466–6474.
295.Lee, DP, Alexander, D & Jonnalgadda, SS (2013) Diversity of nutrient content in grains – a pilot metabolomics analysis. J Nutr Food Sci 3, 10.4172/2155-9600.1000191.
296.Wang, Y, Gapstur, SM, Carter, BD, et al. (2018) Untargeted metabolomics identifies novel potential biomarkers of habitual food intake in a cross-sectional study of postmenopausal women. J Nutr 148, 932–943.
297.Pallister, T, Jennings, A, Mohney, RP, et al. (2016) Characterizing blood metabolomics profiles associated with self-reported food intakes in female twins. PLOS ONE 11, e0158568.
298.Dubost, NJ, Beelman, RB, Peterson, D, et al. (2005) Identification and quantification of ergothioneine in cultivated mushrooms by liquid chromatography–mass spectroscopy. Int J Med Mush 8, 215–222.
299.Dubost, NJ, Beelman, RB & Royse, DJ (2007) Influence of selected cultural factors and postharvest storage on ergothioneine content of common button mushroom Agaricus bisporus (J. Lge) Imbach (Agaricomycetideae). Int J Med Mush 9, 163–176.
300.Kalaras, MD, Richie, JP, Calcagnotto, A, et al. (2017) Mushrooms: a rich source of the antioxidants ergothioneine and glutathione. Food Chem 233, 429–433.
301.Tepwong, P & Ohshima, T (2009) Biosynthesis of ergothioneine during different stages of submerged fermentation of “Shiitake” (Lentinus edodes) mushroom and their bioactive properties. J Biosci Bioeng 108, S4–S5.
302.Tepwong, P, Giri, A & Ohshima, T (2012) Effect of mycelial morphology on ergothioneine production during liquid fermentation of Lentinula edodes. Mycoscience 53, 102–112.
303.Tepwong, P, Giri, A, Sasaki, F, et al. (2012) Mycobial enhancement of ergothioneine by submerged cultivation of edible mushroom mycelia and its application as an antioxidative compound. Food Chem 131, 247–258.
304.Kalaras, MD, Beelman, RB & Elias, RJ (2012) Effects of postharvest pulsed UV light treatment of white button mushrooms (Agaricus bisporus) on vitamin D-2 content and quality attributes. J Agric Food Chem 60, 220–225.
305.Kalaras, MD, Beelman, RB, Holick, MF, et al. (2012) Generation of potentially bioactive ergosterol-derived products following pulsed ultraviolet light exposure of mushrooms (Agaricus bisporus). Food Chem 135, 396–401.
306.Liang, CH, Ho, KJ, Huang, LY, et al. (2013) Antioxidant properties of fruiting bodies, mycelia, and fermented products of the culinary-medicinal king oyster mushroom, Pleurotus eryngii (higher Basidiomycetes), with high ergothioneine content. Int J Med Mushrooms 15, 267–275.
307.Lin, SY, Chien, SC, Wang, SY, et al. (2015) Submerged cultivation of mycelium with high ergothioneine content from the culinary-medicinal golden oyster mushroom, Pleurotus citrinopileatus (higher Basidiomycetes). Int J Med Mushrooms 17, 749–761.
308.Lin, SY, Chien, SC, Wang, SY, et al. (2016) Nonvolatile taste components and antioxidant properties of fruiting body and mycelium with high ergothioneine content from the culinary-medicinal golden oyster mushroom Pleurotus citrinopileatus (Agaricomycetes). Int J Med Mushrooms 18, 689–698.
309.Chen, SY, Ho, KJ, Hsieh, YJ, et al. (2012) Contents of lovastatin, γ-aminobutyric acid and ergothioneine in mushroom fruiting bodies and mycelia. LWT Food Sci Technol 47, 274–278.
310.Peñaloza, W, Davey, CL, Hedger, JN, et al. (1991) Stimulation by potassium ions of the growth of Rhizopus oligosporus during liquid- and solid-substrate fermentations. World J Microbiol Biotechnol 7, 260–268.
311.Peñaloza, W, Davey, CL, Hedger, JN, et al. (1992) Physiological studies on the solid-state quinoa tempe fermentation, using on-line measurements of fungal biomass production. J Sci Food Agric 59, 227–235.
312.Karyadi, D & Lukito, W (1996) Beneficial effects of tempeh in disease prevention and treatment. Nutr Rev 54, S94–S98.
313.Lukito, W (2001) Candidate foods in the Asia-Pacific region for cardiovascular protection: nuts, soy, lentils and tempe. Asia Pac J Clin Nutr 10, 128–133.
314.Nout, MJR & Kiers, JL (2005) Tempe fermentation, innovation and functionality: update into the third millenium. J Appl Microbiol 98, 789–805.
315.Guinard, JX, Myrdal Miller, A, Mills, K, et al. (2016) Consumer acceptance of dishes in which beef has been partially substituted with mushrooms and sodium has been reduced. Appetite 105, 449–459.
316.Myrdal Miller, A, Mills, K, Wong, T, et al. (2014) Flavor-enhancing properties of mushrooms in meat-based dishes in which sodium has been reduced and meat has been partially substituted with mushrooms. J Food Sci 79, S1795–S1804.
317.Royse, DJ, Baars, J & Tan, Q (2017) Current overview of mushroom production in the world. In Edible and Medicinal Mushrooms: Technology and Applications, pp. 5–14 [Zied, DC and Pardo-Giménez, A, editors]. New York: Wiley-Blackwell.
318.Gallego, P, Rojas, A, Falcón, G, et al. (2019) Water-soluble extracts from edible mushrooms (Agaricus bisporus) as inhibitors of hepatitis C viral replication. Food Funct 10, 3758–3767.
319.Schmitz, LK (2015) Bioavailability and antioxidant effect of ergothioneine in human blood. MaRBLe Res Pap 6, 174–183.
320.Dogan, A, Dalar, A, Sadullahoglu, C, et al. (2018) Investigation of the protective effects of horse mushroom (Agaricus arvensis Schaeff.) against carbon tetrachloride-induced oxidative stress in rats. Mol Biol Rep 45, 787–797.
321.Khatun, K, Mahtab, H, Khanam, PA, et al. (2007) Oyster mushroom reduced blood glucose and cholesterol in diabetic subjects. Mymensingh Med J 16, 94–99.
322.Hess, J, Wang, Q, Gould, T, et al. (2018) Impact of Agaricus bisporus mushroom consumption on gut health markers in healthy adults. Nutrients 10, E1402.
323.Chaturvedi, VK, Agarwal, S, Gupta, KK, et al. (2018) Medicinal mushroom: boon for therapeutic applications. 3 Biotech 8, 334.
324.Moro, C, Palacios, I, Lozano, M, et al. (2012) Anti-inflammatory activity of methanolic extracts from edible mushrooms in LPS activated RAW 264.7 macrophages. Food Chem 130, 350–355.
325.Guillamón, E, García-Lafuente, A, Lozano, M, et al. (2010) Edible mushrooms: role in the prevention of cardiovascular diseases. Fitoterapia 81, 715–723.
326.Friedman, M (2015) Chemistry, nutrition, and health-promoting properties of Hericium erinaceus (lion’s mane) mushroom fruiting bodies and mycelia and their bioactive compounds. J Agric Food Chem 63, 7108–7123.
327.Moon, B & Lo, YM (2014) Conventional and novel applications of edible mushrooms in today’s food industry. J Food Process Pres 38, 2146–2153.
328.Tang, C, Hoo, PC, Tan, LT, et al. (2016) Golden needle mushroom: a culinary medicine with evidenced-based biological activities and health promoting properties. Front Pharmacol 7, 474.
329.Jayakumar, T, Sakthivel, M, Thomas, PA, et al. (2008) Pleurotus ostreatus, an oyster mushroom, decreases the oxidative stress induced by carbon tetrachloride in rat kidneys, heart and brain. Chem-Biol Interact 176, 108–120.
330.Jayakumar, T, Thomas, PA, Sheu, JR, et al. (2011) In vitro and in vivo antioxidant effects of the oyster mushroom Pleurotus ostreatus. Food Res Int 44, 851–861.
331.Jayakumar, T, Thomas, PA, Ramesh, E, et al. (2010) An extract of the Pleurotus ostreatus mushroom bolsters the glutathione redox system in various organs of aged rats. J Med Food 13, 771–778.
332.Rahman, MA, Abdullah, N & Aminudin, N (2017) Corroborative assessment of mushroom as the graceful ageing and lifespan promoting agent. Biointerface Res App 7, 2072–2083.
333.Rahman, MA, Abdullah, N & Aminudin, N (2016) Interpretation of mushroom as a common therapeutic agent for Alzheimer’s disease and cardiovascular diseases. Crit Rev Biotechnol 36, 1131–1142.
334.Feeney, MJ, Dwyer, J, Hasler-Lewis, CM, et al. (2014) Mushrooms and health summit proceedings. J Nutr 144, 1128S–1136S.
335.Feeney, MJ, Miller, AM, Roupas, P (2014) Mushrooms – biologically distinct and nutritionally unique: exploring a “third food kingdom”. Nutr Today 49, 301–307.
336.Kawaguchi, Y, Nirengi, S, Kotani, K, et al. (2017) Mushroom intake and advanced glycation end products in the skin among community-dwelling elderly subjects: preliminary data. J Biomed 2, 8–11.
337.Benson, KF, Ager, DM, Landes, B, et al. (2012) Improvement of joint range of motion (ROM) and reduction of chronic pain after consumption of an ergothioneine-containing nutritional supplement. Prev Med 54, Suppl., S83–S89.
338.Gargano, ML, van Griensven, LJLD, Isikhuemhen, OS, et al. (2017) Medicinal mushrooms: valuable biological resources of high exploitation potential. Plant Biosystems 151, 548–565.
339.Khan, MA & Tania, M (2012) Nutritional and medicinal importance of Pleurotus mushrooms: an overview. Food Rev Int 28, 313–329.
340.Calvo, MS, Mehrotra, A, Beelman, RB, et al. (2016) A retrospective study in adults with metabolic syndrome: diabetic risk factor response to daily consumption of Agaricus bisporus (white button mushrooms). Plant Foods Hum Nutr 71, 245–251.
341.Mori, K, Inatomi, S, Ouchi, K, et al. (2009) Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res 23, 367–372.
342.Roncero-Ramos, I & Delgado-Andrade, C (2017) The beneficial role of edible mushrooms in human health. Curr Opin Food Sci 14, 122–128.
343.Reis, FS, Martins, A, Vasconcelos, MH, et al. (2017) Functional foods based on extracts or compounds derived from mushrooms. Trends Food Sci Tech 66, 48–62.
344.Soković, M, Glamočlija, J, Ćirić, A, et al. (2018) Mushrooms as sources of therapeutic foods. In Therapeutic Foods, vol. 8, pp. 141–178 [Holban, AM and Grumezescu, AM, editors]. Cambridge, MA: Academy Press.
345.Trovato Salinaro, A, Pennisi, M, Di Paola, R, et al. (2018) Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer’s disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms. Immun Ageing 15, 8.
346.Valverde, ME, Hernandez-Perez, T & Paredes-Lopez, O (2015) Edible mushrooms: improving human health and promoting quality life. Int J Microbiol 2015, 376387.
347.Muszyńska, B, Grzywacz-Kisielewska, A, Kała, K, et al. (2018) Anti-inflammatory properties of edible mushrooms: a review. Food Chem 243, 373–381.
348.Feng, L, Cheah, IK, Ng, MM, et al. (2019) The association between mushroom consumption and mild cognitive impairment: a community-based cross-sectional study in Singapore. J Alzheimers Dis 68, 197–203.
349.Poddar, KH, Ames, M, Hsin-Jen, C, et al. (2013) Positive effect of mushrooms substituted for meat on body weight, body composition, and health parameters. A 1-year randomized clinical trial. Appetite 71, 379–387.
350.Hodge, AM & Calvo, MS (2019) Do bioactive components in non-animal food sources contribute to the beneficial health effect of a Japanese dietary pattern? Public Health Nutr 22, 2469–2471.
351.Zembron-Lacny, A, Gajewski, M, Naczk, M, et al. (2013) Effect of shiitake (Lentinus edodes) extract on antioxidant and inflammatory response to prolonged eccentric exercise. J Physiol Pharmacol 64, 249–254.
352.Jayachandran, M, Xiao, J & Xu, B (2017) A critical review on health promoting benefits of edible mushrooms through gut microbiota. Int J Mol Sci 18, E1934.
353.Maier, L, Pruteanu, M, Kuhn, M, et al. (2018) Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623–628.
354.Schmutz, M, Carron, PN, Yersin, B, et al. (2018) Mushroom poisoning: a retrospective study concerning 11-years of admissions in a Swiss emergency department. Intern Emerg Med 13, 59–67.
355.Chan, CK, Lam, HC, Chiu, SW, et al. (2016) Mushroom poisoning in Hong Kong: a ten-year review. Hong Kong Med J 22, 124–130.
356.Verma, N, Bhalla, A, Kumar, S, et al. (2014) Wild mushroom poisoning in north India: case series with review of literature. J Clin Exp Hepatol 4, 361–365.
357.White, J, Weinstein, SA, De Haro, L, et al. (2019) Mushroom poisoning: a proposed new clinical classification. Toxicon 157, 53–65.
358.Ramirez-Martinez, A, Wesolek, N, Yadan, JC, et al. (2016) Intake assessment of l-ergothioneine in some European countries and in the United States. Hum Ecol Risk Assess 22, 667–677.
359.Marone, PA, Trampota, J, Weisman, S (2016) A safety evaluation of a nature-identical l-ergothioneine in Sprague Dawley rats. Int J Toxicol 35, 568–583.
360.Cheah, IK, Tang, RMY, Yew, TSZ, et al. (2017) Administration of pure ergothioneine to healthy human subjects: uptake, metabolism, and effects on biomarkers of oxidative damage and inflammation. Antioxid Redox Signal 26, 193–206.
361.Turck, D, Bresson, JL, Burlingame, B, et al. (2016) Safety of synthetic l-ergothioneine (Ergoneine (R)) as a novel food pursuant to Regulation (EC) No 258/97. EFSA J 14, 4629.
362.Turck, D, Bresson, JL, Burlingame, B, et al. (2017) Statement on the safety of synthetic l-ergothioneine as a novel food – supplementary dietary exposure and safety assessment for infants and young children, pregnant and breastfeeding women. EFSA J 15, 5060.
363.Schauss, AG, Vértesi, A, Endres, JR, et al. (2010) Evaluation of the safety of the dietary antioxidant ergothioneine using the bacterial reverse mutation assay. Toxicology 278, 39–45.
364.Schauss, AG, Béres, E, Vértesi, A, et al. (2011) The effect of ergothioneine on clastogenic potential and mutagenic activity: genotoxicity evaluation. Int J Toxicol 30, 405–409.
365.Hunter, G (1928) A new test for ergothioneine upon which is based a method for its estimation in simple solution and in blood-filtrates. Biochem J 22, 4–10.
366.Melville, DB & Lubschez, R (1953) A method for the determination of ergothioneine in blood. J Biol Chem 200, 275–285.
367.Carlsson, J, Kierstan, MP & Brocklehurst, K (1974) A convenient spectrophotometric assay for the determination of l-ergothioneine in blood. Biochem J 139, 237–242.
368.Sotgia, S, Arru, D, Sotgiu, E, et al. (2016) Simultaneous determination of the main amino thiol and thione in human whole blood by CE and LC. Bioanalysis 8, 945–951.
369.Sotgia, S, Pisanu, E, Pintus, G, et al. (2013) Plasma l-ergothioneine measurement by high-performance liquid chromatography and capillary electrophoresis after a pre-column derivatization with 5-iodoacetamidofluorescein (5-IAF) and fluorescence detection. PLOS ONE 8, e70374.
370.Zhou, T, Liu, Q, Jiang, W, et al. (2012) A new strategy for quantitative analysis of ergothioneine in fermentation broth by RP-HPLC. Lect Notes Elec Eng 249, 313–321.
371.Mayumi, T, Kawano, H, Sakamoto, Y, et al. (1978) Studies on ergothioneine. V. Determination by high performance liquid chromatography and application to metabolic research. Chem Pharm Bull (Tokyo) 26, 3772–3778.
372.Sotgia, S, Zinellu, A, Arru, D, et al. (2015) Amniotic fluid l-ergothioneine concentrations in pregnant sheep after natural mating and transfer of vitrified/thawed in-vitro produced embryos. Res Vet Sci 102, 238–241.
373.Liu, Q, Zhang, W, Wang, H, et al. (2016) Validation of a HILIC method for the analysis of ergothioneine in fermentation broth. J Chromatogr Sci 54, 934–938.
374.Muda, M, Pelizzoni, F, Sello, G, et al. (1988) Determination of ergothioneine in red blood cells by high-performance liquid chromatography. J Chromatogr 434, 191–195.
375.Newton, GL, Dorian, R & Fahey, RC (1981) Analysis of biological thiols: derivatization with monobromobimane and separation by reverse-phase high-performance liquid chromatography. Anal Biochem 114, 383–387.
376.Bello, MH, Mogannam, JC, Morin, D, et al. (2014) Endogenous ergothioneine is required for wild type levels of conidiogenesis and conidial survival but does not protect against 254 nm UV-induced mutagenesis or kill. Fungal Genet Biol 73, 120–127.
377.Fahey, RC & Newton, GL (1987) Determination of low-molecular-weight thiols using monobromobimane fluorescent labeling and high-performance liquid chromatography. Methods Enzymol 143, 85–96.
378.Sotgia, S, Pisanu, E, Cambedda, D, et al. (2014) Ultra-performance liquid chromatographic determination of l-ergothioneine in commercially available classes of cow milk. J Food Sci 79, C1683–C1687.
379.Kuninori, T & Nishiyama, J (1991) Measurement of biological thiols and disulfides by high-performance liquid chromatography and electrochemical detection of silver mercaptide formation. Anal Biochem 197, 19–24.
380.Kroepfl, N, Francesconi, KA, Schwerdtle, T, et al. (2019) Selenoneine and ergothioneine in human blood cells determined simultaneously by HPLC/ICPQQQ-MS. J Anal At Spectrom 34, 127–134.
381.Bashir, R (2017) Bio-analytical screening and characterization of antioxidant compounds using online liquid chromatography techniques and mass spectrometry. Thesis for Doctor of Philosophy, Swinburne University of Technology.
382.Sotgia, S, Zinellu, A, Pintus, G, et al. (2013) Quantification of l-ergothioneine in whole blood by hydrophilic interaction ultra-performance liquid chromatography and UV-detection. J Sep Sci 36, 1002–1006.
383.Sakurai, H & Takeshima, S (1977) Acid dissociation of 2-mercaptohistamine and its related compounds. Talanta 24, 531–532.
384.Bessieres, MA, Gibon, Y, Lefeuvre, JC, et al. (1999) A single-step purification for glycine betaine determination in plant extracts by isocratic HPLC. J Agric Food Chem 47, 3718–3722.
385.Kar, JR & Singhal, RS (2017) Pilot scale production, kinetic modeling, and purification of glycine betaine and trehalose produced from Actinopolyspora halophila (MTCC 263) using acid whey: a dairy industry effluent. Chem Eng Sci 163, 83–91.
386.Bubnik, Z, Pour, V, Gruberova, A, et al. (2004) Application of continuous chromatographic separation in sugar processing. J Food Eng 61, 509–513.
387.Kumosani, TA (2001) l-Ergothioneine level in red blood cells of healthy human males in the Western province of Saudi Arabia. Exp Mol Med 33, 20–22.
388.Baldridge, RC & Lewis, HB (1953) Diet and the ergothioneine content of blood. J Biol Chem 202, 169–176.
389.Baldridge, RC (1955) Blood ergothioneine and dietary oats. J Nutr 56, 107–113.
390.Teruya, T, Chaleckis, R, Takada, J, et al. (2019) Diverse metabolic reactions activated during 58-hr fasting are revealed by non-targeted metabolomic analysis of human blood. Sci Rep 9, 854.
391.Cheah, IK, Feng, L, Tang, RMY, et al. (2016) Ergothioneine levels in an elderly population decrease with age and incidence of cognitive decline; a risk factor for neurodegeneration? Biochem Biophys Res Commun 478, 162–167.
392.Yan, S, Wu, B, Lin, Z, et al. (2009) Metabonomic characterization of aging and investigation on the anti-aging effects of total flavones of Epimedium. Mol Biosyst 5, 1204–1213.
393.Dang, VT, Shi, Y & Werstuck, G (2015) Comprehensive metabolomic analysis of diabetic atherosclerosis. Can J Cardiol 31, S229.
394.Leone, E, Mann, T (1951) Ergothioneine in the seminal vesicle secretion. Nature 168, 205–206.
395.Strzeżek, R, Koziorowska-Gilun, M, Kowalowka, M, et al. (2009) Characteristics of antioxidant system in dog semen. Pol J Vet Sci 12, 55–60.
396.Strzeżek, R, Koziorowska-Gilun, M, Kielczewski, K, et al. (2015) Effect of dialysis of dog semen on sperm characteristics and some biochemical components of seminal plasma. Pol J Vet Sci 18, 447–448.
397.Kenny, LC & Kell, DB (2018) Immunological tolerance, pregnancy and preeclampsia: the roles of semen microbes and the father. Front Med Obs Gynecol 4, 239.
398.Forster, R, Spézia, F, Papineau, D, et al. (2015) Reproductive safety evaluation of l-ergothioneine. Food Chem Toxicol 80, 85–91.
399.Mishra, A, Reddy, IJ, Dhali, A, et al. (2018) l-Ergothioneine improves the developmental potential of in vitro sheep embryos without influencing OCTN1-mediated cross-membrane transcript expression. Zygote 26, 149–161.
400.Shukla, Y, Kulshrestha, OP & Khuteta, KP (1981) Ergothioneine content in normal and senile human cataractous lenses. Indian J Med Res 73, 472–473.
401.Kato, Y, Kubo, Y, Iwata, D, et al. (2010) Gene knockout and metabolome analysis of carnitine/organic cation transporter OCTN1. Pharm Res 27, 832–840.
402.Chaleckis, R, Murakami, I, Takada, J, et al. (2016) Individual variability in human blood metabolites identifies age-related differences. Proc Natl Acad Sci U S A 113, 4252–4259.
403.Jose, JM (2011) Ergothioneine degradation and properties of ergothionase from Agrobacterium radiobacter. BSc Thesis, Penn State University.
404.Kelly, B, Appleman, MD (1961) Degradation of ergothioneine by cell-free extracts of Alcaligenes faecalis. J Bacteriol 81, 715–720.
405.Muramatsu, H, Matsuo, H, Okada, N, et al. (2013) Characterization of ergothionase from Burkholderia sp. HME13 and its application to enzymatic quantification of ergothioneine. Appl Microbiol Biotechnol 97, 5389–5400.
406.Yanasugondha, D & Appleman, MD (1957) Degradation of ergothioneine by Alcaligenes faecalis. J Bacteriol 74, 381–385.
407.Fennema, D, Phillips, IR & Shephard, EA (2016) Trimethylamine and trimethylamine N-oxide, a flavin-containing monooxygenase 3 (FMO3)-mediated host-microbiome metabolic axis implicated in health and disease. Drug Metab Dispos 44, 1839–1850.
408.Wolff, JB (1962) Ergothionase from Escherichia coli. J Biol Chem 237, 874–881.
409.Maurer, A, Leisinger, F, Lim, D, et al. (2019) Structure and mechanism of ergothionase from Treponema denticola. Chemistry 25, 10298–10303.
410.Booth, JS, Appleman, MD (1963) Degradation of ergothioneine by cell-free extracts of Alcaligenes faecalis. II. Production of glutamic acid. J Bacteriol 85, 654–657.
411.Cheah, IK, Ong, RL, Gruber, J, et al. (2013) Knockout of a putative ergothioneine transporter in Caenorhabditis elegans decreases lifespan and increases susceptibility to oxidative damage. Free Radic Res 47, 1036–1045.
412.Ben Said, M, Grati, M, Ishimoto, T, et al. (2016) A mutation in SLC22A4 encoding an organic cation transporter expressed in the cochlea strial endothelium causes human recessive non-syndromic hearing loss DFNB60. Hum Genet 135, 513–524.
413.Urban, TJ, Yang, C, Lagpacan, LL, et al. (2007) Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4). Pharmacogenet Genomics 17, 773–782.
414.Toh, DSL, Koo, SH, Limenta, LMG, et al. (2009) Genetic variations of the SLC22A4 gene in Chinese and Indian populations of Singapore. Drug Metab Pharmacokinet 24, 475–481.
415.Toh, DSL, Cheung, FSG, Murray, M, et al. (2013) Functional analysis of novel variants in the organic cation/ergothioneine transporter 1 identified in Singapore populations. Mol Pharm 10, 2509–2516.
416.Mathieson, I, Lazaridis, I, Rohland, N, et al. (2015) Genome-wide patterns of selection in 230 ancient Eurasians. Nature 528, 499–503.
417.Yamase, Y, Horibe, H, Ueyama, C, et al. (2015) Association of TOMM40 and SLC22A4 polymorphisms with ischemic stroke. Biomed Rep 3, 491–498.
418.Nakamura, T, Sugiura, S, Kobayashi, D, et al. (2007) Decreased proliferation and erythroid differentiation of K562 cells by siRNA-induced depression of OCTN1 (SLC22A4) transporter gene. Pharm Res 24, 1628–1635.
419.Maeda, T, Hirayama, M, Kobayashi, D, et al. (2007) Mechanism of the regulation of organic cation/carnitine transporter 1 (SLC22A4) by rheumatoid arthritis-associated transcriptional factor RUNX1 and inflammatory cytokines. Drug Metab Dispos 35, 394–401.
420.Tokuhiro, S, Yamada, R, Chang, X, et al. (2003) An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 35, 341–348.
421.Reglinski, J, Smith, WE & Sturrock, RD (1988) Spin-echo 1H NMR detected response of ergothioneine to oxidative stress in the intact human erythrocyte. Magn Reson Med 6, 217–223.
422.Takata, Y, Inoue, H, Sato, A, et al. (2008) Replication of reported genetic associations of PADI4, FCRL3, SLC22A4 and RUNX1 genes with rheumatoid arthritis: results of an independent Japanese population and evidence from meta-analysis of East Asian studies. J Hum Genet 53, 163–173.
423.Barton, A, Eyre, S, Bowes, J, et al. (2005) Investigation of the SLC22A4 gene (associated with rheumatoid arthritis in a Japanese population) in a United Kingdom population of rheumatoid arthritis patients. Arthritis Rheum 52, 752–758.
424.Han, TU, Lee, HS, Kang, C, et al. (2015) Association of joint erosion with SLC22A4 gene polymorphisms inconsistently associated with rheumatoid arthritis susceptibility. Autoimmunity 48, 313–317.
425.Martínez, A, Valdivia, A, Pascual-Salcedo, D, et al. (2006) Role of SLC22A4, SLC22A5, and RUNX1 genes in rheumatoid arthritis. J Rheumatol 33, 842–846.
426.Yamada, R, Tokuhiro, S, Chang, X, et al. (2004) SLC22A4 and RUNX1: identification of RA susceptible genes. J Mol Med (Berl) 82, 558–564.
427.Lee, YH, Bae, SC, Kim, JH, et al. (2015) Meta-analysis of SLC22A4 and RUNX1 polymorphisms: associations with rheumatoid arthritis susceptibility. Z Rheumatol 74, 351–358.
428.Orozco, G, Sánchez, E, Gómez, LM, et al. (2006) Study of the role of functional variants of SLC22A4, RUNX1 and SUMO4 in systemic lupus erythematosus. Ann Rheum Dis 65, 791–795.
429.Taubert, D, Grimberg, G, Jung, N, et al. (2005) Functional role of the 503F variant of the organic cation transporter OCTN1 in Crohn’s disease. Gut 54, 1505–1506.
430.Taubert, D, Jung, N, Goeser, T, et al. (2009) Increased ergothioneine tissue concentrations in carriers of the Crohn’s disease risk-associated 503F variant of the organic cation transporter OCTN1. Gut 58, 312–314.
431.Jung, ES, Park, HJ, Kong, KA, et al. (2017) Association study between OCTN1 functional haplotypes and Crohn’s disease in a Korean population. Korean J Physiol Pharmacol 21, 11–17.
432.Lai, Y, Xue, J, Liu, CW, et al. (2019) Serum metabolomics identifies altered bioenergetics, signaling cascades in parallel with exposome markers in Crohn’s disease. Molecules 24, 449.
433.Huff, CD, Witherspoon, DJ, Zhang, Y, et al. (2012) Crohn’s disease and genetic hitchhiking at IBD5. Mol Biol Evol 29, 101–111.
434.Peltekova, VD, Wintle, RF, Rubin, LA, et al. (2004) Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36, 471–475.
435.Newman, B, Gu, X, Wintle, R, et al. (2005) A risk haplotype in the solute carrier family 22A4/22A5 gene cluster influences phenotypic expression of Crohn’s disease. Gastroenterology 128, 260–269.
436.Leung, E, Hong, J, Fraser, AG, et al. (2006) Polymorphisms in the organic cation transporter genes SLC22A4 and SLC22A5 and Crohn’s disease in a New Zealand Caucasian cohort. Immunol Cell Biol 84, 233–236.
437.Santiago, JL, Martinez, A, de la Calle, H, et al. (2006) Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: a case control study. BMC Med Genet 7, 54.
438.Zhao, Z, Reece, EA (2013) New concepts in diabetic embryopathy. Clin Lab Med 33, 207–233.
439.Wada, E, Koyanagi, S, Kusunose, N, et al. (2015) Modulation of peroxisome proliferator-activated receptor-α activity by bile acids causes circadian changes in the intestinal expression of Octn1/Slc22a4 in mice. Mol Pharmacol 87, 314–322.
440.Mestres, J, Gregori-Puigjané, E, Valverde, S, et al. (2009) The topology of drug-target interaction networks: implicit dependence on drug properties and target families. Mol Biosyst 5, 1051–1057.
441.Kell, DB (2006) Metabolomics, modelling and machine learning in systems biology: towards an understanding of the languages of cells. The 2005 Theodor Bücher lecture. FEBS J 273, 873–894.
442.Palsson, BØ (2015) Systems Biology: Constraint-Based Reconstruction and Analysis. Cambridge: Cambridge University Press.
443.Sastry, AV, Gao, Y, Szubin, R, et al. (2019) The Escherichia coli transcriptome consists of independently regulated modules. Nat Commun 10, 5536.
444.Kell, DB (2005) Metabolomics, machine learning and modelling: towards an understanding of the language of cells. Biochem Soc Trans 33, 520–524.
445.Kell, DB & Knowles, JD (2006) The role of modeling in systems biology. In System Modeling in Cellular Biology: From Concepts to Nuts and Bolts, pp. 3–18 [Szallasi, Z, Stelling, J and Periwal, V, editors]. Cambridge, MA: MIT Press.
446.Ihekwaba, AEC, Broomhead, DS, Grimley, R, et al. (2004) Sensitivity analysis of parameters controlling oscillatory signalling in the NF-kB pathway: the roles of IKK and IkBa. Systems Biol 1, 93–103.
447.Saltelli, A, Tarantola, S, Campolongo, F, et al. (2004) Sensitivity Analysis in Practice: A Guide to Assessing Scientific Models. New York: Wiley.
448.Rand, DA (2008) Mapping global sensitivity of cellular network dynamics: sensitivity heat maps and a global summation law. J R Soc Interface 5, Suppl. 1, S59–S69.
449.Kell, DB & Oliver, SG (2004) Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era. Bioessays 26, 99–105.
450.Ledoux, AC & Perkins, ND (2014) NF-κB and the cell cycle. Biochem Soc Trans 42, 76–81.
451.Perkins, ND (2012) The diverse and complex roles of NF-κB subunits in cancer. Nat Rev Cancer 12, 121–132.
452.Shih, RH, Wang, CY & Yang, CM (2015) NF-κB signaling pathways in neurological inflammation: a mini review. Front Mol Neurosci 8, 77.
453.Nelson, DE, Ihekwaba, AEC, Elliott, M, et al. (2004) Oscillations in NF-kB signalling control the dynamics of gene expression. Science 306, 704–708.
454.Ashall, L, Horton, CA, Nelson, DE, et al. (2009) Pulsatile stimulation determines timing and specificity of NFκ-B-dependent transcription. Science 324, 242–246.
455.Buelna-Chontal, M & Zazueta, C (2013) Redox activation of Nrf2 & NF-κB: a double end sword? Cell Signal 25, 2548–2557.
456.Kaur, U, Banerjee, P, Bir, A, et al. (2015) Reactive oxygen species, redox signaling and neuroinflammation in Alzheimer’s disease: the NF-κB connection. Curr Top Med Chem 15, 446–457.
457.Lepetsos, P, Papavassiliou, KA & Papavassiliou, AG (2019) Redox and NF-κB signaling in osteoarthritis. Free Radic Biol Med 132, 90–100.
458.Gao, G & Dudley, SC Jr (2009) Redox regulation, NF-κB, and atrial fibrillation. Antioxid Redox Signal 11, 2265–2277.
459.Xiao, L, Zhao, L, Li, T, et al. (2006) Activity of the dietary antioxidant ergothioneine in a virus gene-based assay for inhibitors of HIV transcription. Biofactors 27, 157–165.
460.Rahman, I, Gilmour, PS, Jimenez, LA, et al. (2003) Ergothioneine inhibits oxidative stress- and TNF-α-induced NF-κ B activation and interleukin-8 release in alveolar epithelial cells. Biochem Biophys Res Commun 302, 860–864.
461.Agarwal, A, Aponte-Mellado, A, Premkumar, BJ, et al. (2012) The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol 10, 49.
462.Aouache, R, Biquard, L, Vaiman, D, et al. (2018) Oxidative stress in preeclampsia and placental diseases. Int J Med Sci 19.
463.Wang, J, Schipper, HM, Velly, AM, et al. (2015) Salivary biomarkers of oxidative stress: a critical review. Free Radic Biol Med 85, 95–104.
464.Schrag, M, Mueller, C, Zabel, M, et al. (2013) Oxidative stress in blood in Alzheimer’s disease and mild cognitive impairment: a meta-analysis. Neurobiol Dis 59, 100–110.
465.Jones, DP (2006) Redefining oxidative stress. Antioxid Redox Signal 8, 1865–1879.
466.Rice-Evans, CA & Packer, L (editors) (2003) Flavonoids in Health and Disease, 2nd ed. New York: Marcel Dekker.
467.Halliwell, B & Gutteridge, JMC (2006) Free Radicals in Biology and Medicine, 4th ed. Oxford: Oxford University Press.
468.Halliwell, B & Gutteridge, JMC (2015) Free Radicals in Biology and Medicine, 5th ed. Oxford: Oxford University Press.
469.Deiana, M, Rosa, A, Casu, V, et al. (2004) l-Ergothioneine modulates oxidative damage in the kidney and liver of rats in vivo: studies upon the profile of polyunsaturated fatty acids. Clin Nutr 23, 183–193.
470.Laurenza, I, Colognato, R, Migliore, L, et al. (2008) Modulation of palmitic acid-induced cell death by ergothioneine: evidence of an anti-inflammatory action. Biofactors 33, 237–247.
471.Gökçe, G, Arun, MZ & Ertuna, E (2018) Ergothioneine prevents endothelial dysfunction induced by mercury chloride. Exp Ther Med 15, 4697–4702.
472.Rai, RK, Chalana, A, Karri, R, et al. (2019) Role of hydrogen bonding by thiones in protecting biomolecules from copper(I)-mediated oxidative damage. Inorg Chem 58, 6628–6638
473.Zhu, BZ, Mao, L, Fan, RM, et al. (2011) Ergothioneine prevents copper-induced oxidative damage to DNA and protein by forming a redox-inactive ergothioneine–copper complex. Chem Res Toxicol 24, 30–34.
474.Gokce, G & Arun, MZ (2014) Ergothioneine produces relaxation in isolated rat aorta by inactivating superoxide anion. Eur Rev Med Pharmacol Sci 18, 3339–3345.
475.Pahila, J, Ishikawa, Y & Ohshima, T (2019) Effects of ergothioneine-rich mushroom extract on the oxidative stability of astaxanthin in liposomes. J Agric Food Chem 67, 3491–3501.
476.Cheah, IK, Tang, R, Ye, P, et al. (2016) Liver ergothioneine accumulation in a guinea pig model of non-alcoholic fatty liver disease. A possible mechanism of defence? Free Radic Res 50, 14–25.
477.Sansbury, BE, DeMartino, AM, Xie, Z, et al. (2014) Metabolomic analysis of pressure-overloaded and infarcted mouse hearts. Circ Heart Fail 7, 634–642.
478.Agudo-Barriuso, M, Lahoz, A, Nadal-Nicolás, FM, et al. (2013) Metabolomic changes in the rat retina after optic nerve crush. Invest Ophthalmol Vis Sci 54, 4249–4259.
479.Colognato, R, Laurenza, I, Fontana, I, et al. (2006) Modulation of hydrogen peroxide-induced DNA damage, MAPKs activation and cell death in PC12 by ergothioneine. Clin Nutr 25, 135–145.
480.Song, TY, Chen, CL, Liao, JW, et al. (2010) Ergothioneine protects against neuronal injury induced by cisplatin both in vitro and in vivo. Food Chem Toxicol 48, 3492–3499.
481.Nishida, K, Takeuchi, K, Hosoda, A, et al. (2018) Ergothioneine ameliorates oxaliplatin-induced peripheral neuropathy in rats. Life Sci 207, 516–524.
482.D’Onofrio, N, Servillo, L, Giovane, A, et al. (2016) Ergothioneine oxidation in the protection against high-glucose induced endothelial senescence: involvement of SIRT1 and SIRT6. Free Radic Biol Med 96, 211–222.
483.Gunawardena, D, Bennett, L, Shanmugam, K, et al. (2014) Anti-inflammatory effects of five commercially available mushroom species determined in lipopolysaccharide and interferon-γ activated murine macrophages. Food Chem 148, 92–96.
484.Sakrak, O, Kerem, M, Bedirli, A, et al. (2008) Ergothioneine modulates proinflammatory cytokines and heat shock protein 70 in mesenteric ischemia and reperfusion injury. J Surg Res 144, 36–42.
485.Bedirli, A, Sakrak, O, Muhtaroglu, S, et al. (2004) Ergothioneine pretreatment protects the liver from ischemia–reperfusion injury caused by increasing hepatic heat shock protein 70. J Surg Res 122, 96–102.
486.Arduini, A, Eddy, L & Hochstein, P (1990) The reduction of ferryl myoglobin by ergothioneine: a novel function for ergothioneine. Arch Biochem Biophys 281, 41–43.
487.Zimring, JC, Smith, N, Stowell, SR, et al. (2014) Strain-specific red blood cell storage, metabolism, and eicosanoid generation in a mouse model. Transfusion 54, 137–148.
488.Kell, DB & Pretorius, E (2015) On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death. Integr Biol 7, 1339–1377.
489.Goodman, M, Bostick, RM, Kucuk, O, et al. (2011) Clinical trials of antioxidants as cancer prevention agents: past, present, and future. Free Radic Biol Med 51, 1068–1084.
490.Lloret, A, Esteve, D, Monllor, P, et al. (2019) The effectiveness of vitamin E treatment in Alzheimer’s disease. Int J Mol Sci 20, E879.
491.Lloret, A, Badía, MC, Mora, NJ, et al. (2009) Vitamin E paradox in Alzheimer’s disease: it does not prevent loss of cognition and may even be detrimental. J Alzheimers Dis 17, 143–149.
492.Poston, L, Briley, AL, Seed, PT, et al. (2006) Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 367, 1145–1154.
493.Oldham, KM & Bowen, PE (1998) Oxidative stress in critical care: is antioxidant supplementation beneficial? J Am Diet Assoc 98, 1001–1008.
494.Rehman, A, Collis, CS, Yang, M, et al. (1998) The effects of iron and vitamin C co-supplementation on oxidative damage to DNA in healthy volunteers. Biochem Biophys Res Comm 246, 293–298.
495.Cuzzocrea, S, Riley, DP, Caputi, AP, et al. (2001) Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 53, 135–159.
496.Gilgun-Sherki, Y, Rosenbaum, Z, Melamed, E, et al. (2002) Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev 54, 271–284.
497.Miller, ER 3rd, Pastor-Barriuso, R, Dalal, D, et al. (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142, 37–46.
498.Vaziri, ND & Rodriguez-Iturbe, B (2006) Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension. Nat Clin Pract Nephrol 2, 582–593.
499.Rodrigo, R, Guichard, C & Charles, R (2007) Clinical pharmacology and therapeutic use of antioxidant vitamins. Fund Clin Pharmacol 21, 111–127.
500.Bjelakovic, G, Nikolova, D, Gluud, LL, et al. (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297, 842–857.
501.Bjelakovic, G, Nikolova, D, Gluud, LL, et al. (2008) Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev, issue 2, CD007176.
502.Mendes-da-Silva, RF, Lopes-de-Morais, AA, Bandim-da-Silva, ME, et al. (2014) Prooxidant versus antioxidant brain action of ascorbic acid in well-nourished and malnourished rats as a function of dose: a cortical spreading depression and malondialdehyde analysis. Neuropharmacology 86, 155–160.
503.Zhang, P & Omaye, ST (2001) Antioxidant and prooxidant roles for β-carotene, α-tocopherol and ascorbic acid in human lung cells. Toxicol In Vitro 15, 13–24.
504.Ullah, MF, Khan, HY, Zubair, H, et al. (2011) The antioxidant ascorbic acid mobilizes nuclear copper leading to a prooxidant breakage of cellular DNA: implications for chemotherapeutic action against cancer. Cancer Chemother Pharmacol 67, 103–110.
505.Repine, JE & Elkins, ND (2012) Effect of ergothioneine on acute lung injury and inflammation in cytokine insufflated rats. Prev Med 54, Suppl., S79–S82.
506.Martin, KR (2010) The bioactive agent ergothioneine, a key component of dietary mushrooms, inhibits monocyte binding to endothelial cells characteristic of early cardiovascular disease. J Med Food 13, 1340–1346.
507.Servillo, L, D’Onofrio, N & Balestrieri, ML (2017) Ergothioneine antioxidant function: from chemistry to cardiovascular therapeutic potential. J Cardiovasc Pharmacol 69, 183–191.
508.Darghouth, D, Koehl, B, Heilier, JF, et al. (2011) Alterations of red blood cell metabolome in overhydrated hereditary stomatocytosis. Haematologica 96, 1861–1865.
509.Smith, E, Ottosson, F, Hellstrand, S, et al. (2019) Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease. Heart 2019, heartjnl-2019-315485 (epublication ahead of print version 31 October 2019).
510.Nurk, E, Refsum, H, Drevon, CA, et al. (2010) Cognitive performance among the elderly in relation to the intake of plant foods. The Hordaland Health Study. Br J Nutr 104, 1190–1201.
511.Zhang, S, Tomata, Y, Sugiyama, K, et al. (2017) Mushroom consumption and incident dementia in elderly Japanese: the Ohsaki Cohort 2006 Study. J Am Geriatr Soc 65, 1462–1469.
512.Phan, CW, David, P & Sabaratnam, V (2017) Edible and medicinal mushrooms: emerging brain food for the mitigation of neurodegenerative diseases. J Med Food 20, 1–10.
513.Thangthaeng, N, Miller, MG, Gomes, SM, et al. (2015) Daily supplementation with mushroom (Agaricus bisporus) improves balance and working memory in aged rats. Nutr Res 35, 1079–1084.
514.Tsuk, S, Lev, YH, Rotstein, A, et al. (2017) Clinical effects of a commercial supplement of Ophiocordyceps sinensis and Ganoderma lucidum on cognitive function of healthy young volunteers. Int J Med Mushrooms 19, 667–673.
515.Hatano, T, Saiki, S, Okuzumi, A, et al. (2016) Identification of novel biomarkers for Parkinson’s disease by metabolomic technologies. J Neurol Neurosurg Psychiatry 87, 295–301.
516.Hang, L, Basil, AH & Lim, KL (2016) Nutraceuticals in Parkinson’s disease. Neuromolecular Med 18, 306–321.
517.Shao, Y & Le, W (2019) Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease. Mol Neurodegener 14, 3.
518.Shah, SP & Duda, JE (2015) Dietary modifications in Parkinson’s disease: a neuroprotective intervention? Med Hypotheses 85, 1002–1005.
519.Graham, SF, Chevallier, OP, Kumar, P, et al. (2017) Metabolomic profiling of brain from infants who died from sudden infant death syndrome reveals novel predictive biomarkers. J Perinatol 37, 91–97.
520.Yang, NC, Lin, HC, Wu, JH, et al. (2012) Ergothioneine protects against neuronal injury induced by β-amyloid in mice. Food Chem Toxicol 50, 3902–3911.
521.Cheah, IK, Ng, LT, Ng, LF, et al. (2019) Inhibition of amyloid-induced toxicity by ergothioneine in a transgenic Caenorhabditis elegans model. FEBS Lett 593, 2139–2150.
522.Nakamichi, N, Nakayama, K, Ishimoto, T, et al. (2016) Food-derived hydrophilic antioxidant ergothioneine is distributed to the brain and exerts antidepressant effect in mice. Brain Behav 6, e00477.
523.Logan, AS, Nienaber, U & Pan, XS (editors) (2013) Lipid Oxidation: Challenges in Food Systems. Urbana, IL: AOCS Press.
524.Gray, JI, Gomaa, EA & Buckley, DJ (1996) Oxidative quality and shelf life of meats. Meat Sci 43, S111–S123.
525.Gülçin, I (2012) Antioxidant activity of food constituents: an overview. Arch Toxicol 86, 345–391.
526.Perron, NR & Brumaghim, JL (2009) A review of the antioxidant mechanisms of polyphenol compounds related to iron binding. Cell Biochem Biophys 53, 75–100.
527.Hanlon, DP (1971) Interaction of ergothioneine with metal ions and metalloenzymes. J Med Chem 14, 1084–1087.
528.Encarnacion, AB, Fagutao, F, Hirono, I, et al. (2010) Effects of ergothioneine from mushrooms (Flammulina velutipes) on melanosis and lipid oxidation of kuruma shrimp (Marsupenaeus japonicus). J Agric Food Chem 58, 2577–2585.
529.Encarnacion, AB, Fagutao, F, Hirayama, J, et al. (2011) Edible mushroom (Flammulina velutipes) extract inhibits melanosis in Kuruma shrimp (Marsupenaeus japonicus). J Food Sci 76, C52–C58.
530.Bao, HND, Ushio, H & Ohshima, T (2009) Antioxidative activities of mushroom (Flammulina velutipes) extract added to bigeye tuna meat: dose-dependent efficacy and comparison with other biological antioxidants. J Food Sci 74, C162–C169.
531.Encarnacion, AB, Fagutao, F, Jintasataporn, O, et al. (2012) Application of ergothioneine-rich extract from an edible mushroom Flammulina velutipes for melanosis prevention in shrimp, Penaeus monodon and Litopenaeus vannamei. Food Res Int 45, 232–237.
532.Cai, LY, Li, XP, Wu, XS, et al. (2014) Effect of chitosan coating enriched with ergothioneine on quality changes of Japanese sea bass (Lateolabrax japonicas). Food Bioproc Technol 7, 2281–2290.
533.Pahila, J, Kaneda, H, Nagasaka, R, et al. (2017) Effects of ergothioneine-rich mushroom extracts on lipid oxidation and discoloration in salmon muscle stored at low temperatures. Food Chem 233, 273–281.
534.Bao, HND, Ushio, H & Ohshima, T (2008) Antioxidative activity and antidiscoloration efficacy of ergothioneine in mushroom (Flammulina velutipes) extract added to beef and fish meats. J Agric Food Chem 56, 10032–10040.
535.Bao, HND, Osako, K & Ohshima, T (2010) Value-added use of mushroom ergothioneine as a colour stabilizer in processed fish meats. J Sci Food Agric 90, 1634–1641.
536.Muszyńska, B & Sułkowska-Ziaja, K (2015) Impact of food processing on non-hallucinogenic indole derivatives in edible mushrooms. In Processing and Impact on Active Components in Food, pp. 55–62 [Preedy, V, editor]. San Diego, CA: Academic Press.
537.Cremades, O, Diaz-Herrero, MM, Carbonero-Aguilar, P, et al. (2015) White button mushroom ergothione in eaqueous extracts obtained by the application of enzymes and membrane technology. Food Biosci 10, 42–47.
538.Sánchez, C (2017) Reactive oxygen species and antioxidant properties from mushrooms. Synth Syst Biotechnol 2, 13–22.
539.Duy Bao, HN & Ohshima, T (2013) Strategies to minimize oxidative deterioration in aquatic food products: application of natural antioxidants from edible mushrooms. In Lipid Oxidation, pp. 345–380 [Nienaber, U and Pan, X, editors]. Urbana, IL: AOCS Press.
540.Pérez-Sánchez, A, Barrajón-Catalán, E, Herranz-López, M, et al. (2018) Nutraceuticals for skin care: a comprehensive review of human clinical studies. Nutrients 10, E403.
541.Lee, CM (2016) Fifty years of research and development of cosmeceuticals: a contemporary review. J Cosmet Dermatol 15, 527–539.
542.Epstein, H (2009) Cosmeceuticals and polyphenols. Clin Dermatol 27, 475–478.
543.Taofiq, O, González-Paramás, AM, Martins, A, et al. (2016) Mushrooms extracts and compounds in cosmetics, cosmeceuticals and nutricosmetics – a review. Industrial Crops Products 90, 38–48.
544.Wu, Y, Choi, M-H, Li, J, et al. (2016) Mushroom cosmetics: the present and future. Cosmetics 3, 22.
545.Linder, J (2012) Cosmeceutical treatment of the aging face. In Aesthetic Medicine, pp. 69–84 [Prendergast, PM and Shiffman, MA, editors]. Berlin: Springer.
546.Cronin, H, Draelos, ZD (2010) Top 10 botanical ingredients in 2010 anti-aging creams. J Cosmet Dermatol 9, 218–225.
547.Souyoul, SA, Saussy, KP & Lupo, MP (2018) Nutraceuticals: a review. Dermatol Ther (Heidelb) 8, 5–16.
548.Norins, AL (1962) Free radical formation in the skin following exposure to ultraviolet light. J Invest Dermatol 39, 445–448.
549.Hseu, YC, Lo, HW, Korivi, M, et al. (2015) Dermato-protective properties of ergothioneine through induction of Nrf2/ARE-mediated antioxidant genes in UVA-irradiated human keratinocytes. Free Radic Biol Med 86, 102–117.
550.Botta, C, Di Giorgio, C, Sabatier, AS, et al. (2008) Genotoxicity of visible light (400–800 nm) and photoprotection assessment of ectoin, l-ergothioneine and mannitol and four sunscreens. J Photochem Photobiol B 91, 24–34.
551.Bazela, K, Solyga-Zurek, A, Debowska, R, et al. (2014) l-Ergothioneine protects skin cells against UV-induced damage – a preliminary study. Cosmetics 1, 51–60.
552.Sao Emani, C, Williams, MJ, Van Helden, PD, et al. (2018) γ-Glutamylcysteine protects ergothioneine-deficient Mycobacterium tuberculosis mutants against oxidative and nitrosative stress. Biochem Biophys Res Commun 495, 174–178.
553.Sao Emani, C, Williams, MJ, Van Helden, PD, et al. (2018) Generation and characterization of thiol-deficient Mycobacterium tuberculosis mutants. Sci Data 5, 180184.
554.Jothivasan, VK & Hamilton, CJ (2008) Mycothiol: synthesis, biosynthesis and biological functions of the major low molecular weight thiol in actinomycetes. Nat Prod Rep 25, 1091–1117.
555.Feng, J, Che, Y, Milse, J, et al. (2006) The gene ncgl2918 encodes a novel maleylpyruvate isomerase that needs mycothiol as cofactor and links mycothiol biosynthesis and gentisate assimilation in Corynebacterium glutamicum. J Biol Chem 281, 10778–10785.
556.Newton, GL, Buchmeier, N & Fahey, RC (2008) Biosynthesis and functions of mycothiol, the unique protective thiol of Actinobacteria. Microbiol Mol Biol Rev 72, 471–494.
557.Bzymek, KP, Newton, GL, Ta, P, et al. (2007) Mycothiol import by Mycobacterium smegmatis and function as a resource for metabolic precursors and energy production. J Bacteriol 189, 6796–6805.
558.Brummel, MC (1985) In search of a physiological function for l-ergothioneine. Med Hypotheses 18, 351–370.
559.Brummel, MC (1989) In search of a physiological function for l-ergothioneine – II. Med Hypotheses 30, 39–48.
560.Wang, M, Zhao, Q & Liu, W (2015) The versatile low-molecular-weight thiols: beyond cell protection. Bioessays 37, 1262–1267.
561.Zhao, Q, Wang, M, Xu, D, et al. (2015) Metabolic coupling of two small-molecule thiols programs the biosynthesis of lincomycin A. Nature 518, 115–119.
562.Goldberg, A (1959) The enzymic formation of haem by the incorporation of iron into protoporphyrin; importance of ascorbic acid, ergothioneine and glutathione. Br J Haematol 5, 150–157.
565.Gamage, AM, Liao, C, Cheah, IK, et al. (2018) The proteobacterial species Burkholderia pseudomallei produces ergothioneine, which enhances virulence in mammalian infection. FASEB J 2018, fj201800716.
566.Heath, H & Wildy, J (1956) Biosynthesis of ergothioneine and histidine by claviceps-purpurea. 1. Incorporation of [2-14C]acetate. Biochem J 64, 612–620.
567.Heath, H & Wildy, J (1957) Biosynthesis of ergothioneine. Nature 179, 196–197.
568.Pan, L, Yu, J, Ren, D, et al. (2019) Metabolomic analysis of significant changes in Lactobacillus casei Zhang during culturing to generation 4,000 under conditions of glucose restriction. J Dairy Sci 102, 3851–3867)
569.Pluskal, T, Nakamura, T, Villar-Briones, A, et al. (2010) Metabolic profiling of the fission yeast S. pombe: quantification of compounds under different temperatures and genetic perturbation. Mol Biosyst 6, 182–198.
570.van der Hoek, SA, Darbani, B, Zugaj, K, et al. (2019) Engineering the yeast Saccharomyces cerevisiae for the production of l-(+)-ergothioneine. bioRxiv, 2019, 667592.
571.Sotgia, S, Zinellu, A, Mangoni, AA, et al. (2014) Clinical and biochemical correlates of serum l-ergothioneine concentrations in community-dwelling middle-aged and older adults. PLOS ONE 9, e84918.
572.Nishigori, H, Hayashi, R, Lee, JW, et al. (1984) Effect of MPG on glucocorticoid-induced cataract formation in developing chick embryo. Invest Ophthalmol Vis Sci 25, 1051–1055.
573.Song, TY, Yang, NC, Chen, CL, et al. (2017) Protective effects and possible mechanisms of ergothioneine and hispidin against methylglyoxal-induced injuries in rat pheochromocytoma cells. Oxid Med Cell Longev 2017, 4824371.
574.Guijarro, MV, Indart, A, Aruoma, OI, et al. (2002) Effects of ergothioneine on diabetic embryopathy in pregnant rats. Food Chem Toxicol 40, 1751–1755.
575.Öztürkler, Y, Yildiz, S, Güngör, O, et al. (2010) The effects of l-ergothioneine and l-ascorbic acid on the in vitro maturation (IVM) and embryonic development (IVC) of sheep oocytes. Kafkas Universitesi Veteriner Fakultesi Dergisi 16, 757–763.
576.Zullo, G, Albero, G, Neglia, G, et al. (2016) l-Ergothioneine supplementation during culture improves quality of bovine in vitro-produced embryos. Theriogenology 85, 688–697.
577.Moncaster, JA, Walsh, DT, Gentleman, SM, et al. (2002) Ergothioneine treatment protects neurons against N-methyl-d-aspartate excitotoxicity in an in vivo rat retinal model. Neurosci Lett 328, 55–59.
578.Kawano, H, Higuchi, F, Mayumi, T, et al. (1982) Studies on ergothioneine. VII. Some effects on ergothioneine on glycolytic metabolism in red blood cells from rats. Chem Pharm Bull (Tokyo) 30, 2611–2613.
579.Kimura, C, Nukina, M, Igarashi, K, et al. (2005) β-Hydroxyergothioneine, a new ergothioneine derivative from the mushroom Lyophyllum connatum, and its protective activity against carbon tetrachloride-induced injury in primary culture hepatocytes. Biosci Biotechnol Biochem 69, 357–363.
580.Yoshida, S, Shime, H, Funami, K, et al. (2017) The anti-oxidant ergothioneine augments the immunomodulatory function of TLR agonists by direct action on macrophages. PLOS ONE 12, e0169360.
581.Yoshida, S, Shime, H, Matsumoto, M, et al. (2019) Anti-oxidative amino acid l-ergothioneine modulates the tumor microenvironment to facilitate adjuvant vaccine immunotherapy. Front Immunol 10, 671.
582.Shinozaki, Y, Furuichi, K, Toyama, T, et al. (2017) Impairment of the carnitine/organic cation transporter l-ergothioneine axis is mediated by intestinal transporter dysfunction in chronic kidney disease. Kidney Int 92, 1356–1369.
583.Menna, P, Salvatorelli, E, Giampietro, R, et al. (2002) Doxorubicin-dependent reduction of ferrylmyoglobin and inhibition of lipid peroxidation: implications for cardiotoxicity of anticancer anthracyclines. Chem Res Toxicol 15, 1179–1189.
584.Song, TY, Lin, HC, Chen, CL, et al. (2014) Ergothioneine and melatonin attenuate oxidative stress and protect against learning and memory deficits in C57BL/6J mice treated with d-galactose. Free Radic Res 48, 1049–1060.
585.Motohashi, N, Mori, I, Sugiura, Y, et al. (1974) Metal complexes of ergothioneine. Chem Pharmaceut Bull 22, 654–657.
586.Motohashi, N, Mori, I & Sugiura, Y (1976) Complexing of copper-ion by ergothioneine. Chem Pharmaceut Bull 24, 2364–2368.
587.Rabenstein, DL & Isab, AA (1982) A proton nuclear magnetic resonance study of the interaction of mercury with intact human erythrocytes. Biochim Biophys Acta 721, 374–384.
588.Hartman, PE & Citardi, MJ (1986) Protection afforded by carnosine and by ergothioneine against bacteriophage-P22 inactivation by gamma-irradiation. Environ Mol Mutagen 8, 35–35.
589.Hartman, Z, Hartman, PE & Owens, RA (1986) Ergothioneine (2-thiol-l-histidine betaine = Et) as an antimutagen – interception of direct-acting mutagens formed from nitrosation of spermidine. Environ Mol Mutagen 8, 36–36.
590.Hartman, Z & Hartman, PE (1987) Interception of some direct-acting mutagens by ergothioneine. Environ Mol Mutagen 10, 3–15.
591.Hartman, PE, Hartman, Z & Citardi, MJ (1988) Ergothioneine, histidine, and two naturally occurring histidine dipeptides as radioprotectors against γ-irradiation inactivation of bacteriophages T4 and P22. Radiat Res 114, 319–330.
592.Ishimoto, T, Nakamichi, N, Hosotani, H, et al. (2014) Organic cation transporter-mediated ergothioneine uptake in mouse neural progenitor cells suppresses proliferation and promotes differentiation into neurons. PLOS ONE 9, e89434.
593.Misiti, F, Castagnola, M, Zuppi, C, et al. (2001) Role of ergothioneine on S-nitrosoglutathione catabolism. Biochem J 356, 799–804.
594.Ishimoto, T, Masuo, Y, Kato, Y, et al. (2019) Ergothioneine-induced neuronal differentiation is mediated through activation of S6K1 and neurotrophin 4/5-TrkB signaling in murine neural stem cells. Cell Signal 53, 269–280.
595.Chaves, NA, Alegria, TGP, Dantas, LS, et al. (2019) Impaired antioxidant capacity causes a disruption of metabolic homeostasis in sickle erythrocytes. Free Radic Biol Med 141, 34–46.
596.Mann, T & Leone, E (1953) Studies on the metabolism of semen. 8. Ergothioneine as a normal constituent of boar seminal plasma. Purification and crystallization. Site of formation and function. Biochem J 53, 140–148.
597.Williamson, RD, McCarthy, FP, Manna, S, et al. (2020) l-(+)-Ergothioneine significantly improves the clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model. Hypertension 75, 561–568.